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Abstract 
 
 Despite its broad anti-infective activity, the biosynthesis of the paradigm 
carbapenem antibiotic, thienamycin, remains largely unknown. Apart from the first two 
biosynthetic steps shared with a simple carbapenem, the pathway sharply diverges to the 
more structurally complex members of this class of β-lactam antibiotics like thienamycin. 
Existing evidence points to three putative cobalamin-dependent, radical S-
adenosylmethionine (RS) enzymes, ThnK, ThnL and ThnP, potentially being responsible 
for assembly of the ethyl side chain at C6, bridgehead epimerization at C5, installation of 
the C2-thioether side chain and C2/3-desaturation. The C2 substituent has been 
demonstrated to be derived from stepwise truncation of coenzyme A, but the timing of 
these events with respect to C2—S bond formation is not known. Using in vitro reactions 
with synthetically-accessed substrates, we show that ThnK of the three apparent 
cobalamin-dependent RS enzymes performs sequential methylations to build out the C6-
ethyl side chain in a stereocontrolled manner. This enzymatic reaction produced the 
expected RS methylase coproducts S-adenosylhomocysteine (SAH) and 5’-
deoxyadenosine (5’-dA) by LC-MS and was also found to require cobalamin. For double 
methylation to occur, the carbapenam substrate must bear a coenzyme A-derived C2-
thioether side chain, implying the activity of a prior sulfur insertion by an unidentified 
enzyme. Heterologous expression of thienamycin biosynthetic enzymes in Streptomyces 
combined with a competition bioassay now implicates ThnL in attachment of the 
thioether. Additional substrate profiling with ThnK suggests that CoA itself is added to 
the bicyclic carbapenam nucleus. These insights allow refinements of the central steps in 
complex carbapenem biosynthesis. 
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β-Lactam Antibiotics: Discovery, Classes, and Mechanism of Action 
 
 The genesis of modern antimicrobial therapy, a turning point for human medicine, 
began with a fortuitous discovery in 1928 by Alexander Fleming when he observed that 
contaminating Penicillium mold killed nearby staphylococcus colonies growing on the 
same plate. As he later reported, “It was found that broth in which the mould had been 
grown at room temperature for one or two weeks had acquired marked inhibitory, 
bactericidal and bacteriolytic properties to many of the more common pathogenic 
bacteria” (1). Fleming reasoned that there was a substance from the mold that could 
function as an antibiotic (1) and many others were involved in the development of this 
compound to a clinical antimicrobial (2), which became known as penicillin. Several 
years later, Dorothy Hodgkin’s crystal structure revealed that penicillin contained a 4-
member cyclic amide called a β-lactam (2, 3), a moiety that would prove to be essential 
to the efficacy of this antibiotic.  
 In addition to penicillin, several other natural β-lactams have been subsequently 
discovered. While all β-lactam antibiotics contain the namesake heterocycle, a possible 
fused second ring as well as additional side chains can differ, forming different β-lactam 
classes. The classes of naturally occurring β-lactams include: the penams (penicillins), 
cephems (cephalosporins, cephamycins), carbapenems (and carbapenams, which lack the 
characteristic double bond), clavams, and monobactams (2, 4). More variations have been 
generated synthetically (2). The core structures of these major classes are depicted in 
Figure 1.1. Derivatives of these natural β-lactams have been very successful clinically, 
2	  
pairing both efficacy and safety and accounting for billions of dollars in annual           
sales (2, 4). 
As single celled organisms, bacteria are surrounded by a peptidoglycan layer that 
aids in the structural integrity of the isolated cell. While both Gram-negative and Gram-
positive bacteria contain peptidoglycan, the layer is generally smaller in Gram-negative 
bacteria, which also possess a second membrane on the outside of this structure. 
Peptidoglycan consists of alternating sugar residues-N-acetylglucosamine (NAG) and N-
acetylmuramic acid (NAM)-that have been polymerized. Attached to the NAM residues 
are small chains of five or more amino acids ending with a D-Ala-D-Ala motif. There are 
transpeptidases (also called high molecular weight penicillin binding proteins) that form a 
peptide bond between an amine on a neighboring chain and the penultimate D-Ala, a 
process that releases the terminal D-Ala residue. β-lactam antibiotics mimic the D-Ala-D-
Ala terminus, a concept termed the Tipper-Strominger Hypothesis, resulting in attack on 
the β-lactam ring by an active site serine of the transpeptidase to form a covalent acyl-
enzyme intermediate. The enzyme is unable to clear the antibiotic from its catalytic 






















center due to distortion of the protein owing to the steric bulk of the antibiotic structure 
and exclusion of a nucleophile, thus effectively inhibiting the transpeptidase from 
performing further catalytic cycles. Figure 1.2 depicts how β-lactams mimic the D-Ala-D-
Ala terminus, react with the active site serine, and block further reaction from occurring 
with the acyl-enzyme intermediate. (2) β-lactams antibiotics eventually kill microbes by 
blocking their ability to maintain their cell wall. This class of antibiotics is specific for 
































Figure 1.2: β-lactams form a stable acyl enzyme intermediate that 
blocks further chemistry by the transpeptidase. Figure is modeled 
from (2). 
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Biosynthesis and Production: Penicillin 
In its native producers, penicillin is made by a nonribosomal peptide synthetase 
(NRPS), δ-(L-α-aminoadipyl)-L-cysteine-D-valine synthetase (ACVS), which forms a 
tripeptide using the amino acids: L-α-aminoadipic acid, L-cysteine, and L-valine.  The 
NRPS is responsible for catalyzing peptide bond formation in an ordered manner and 
epimerization of the L-valine residue.  The resulting product, ACV, is a substrate for 
isopenicillin N synthase (IPNS), a remarkable enzyme requiring iron and oxygen, which 
is able to form the bicycle isopenicillin N. (5) Finally, an acyltransferase is able to 
exchange the L-α-aminoadipic acid moiety for another group such as phenylacetic acid, 
forming penicillin G. This process is outlined in Figure 1.3. Additionally, isopenicillin N 
serves as an intermediate in the biosynthesis of the cephalosporins and cephamycins. (6) 
Efficient in vivo production of penicillins and cephalosporins is now feasible 
because of understanding of penicillin biosynthesis along with the development of 
production strains and fermentation technology. Greater than 90% of penicillin G or V 
can be recovered from producers and high titers of both penicillin (40–50 g/L) and 
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cephalosporin (20–25 g/L) is possible. (7) Isolated fermentative products, such as 6-
aminopenicillanic acid (6-APA), can also be used as intermediates in semi-synthetic 
processes to make penicillin and cephalosporin derivatives (7). 
 
Bacterial Resistance to β-Lactams 
 
 Although important antibiotics, the β-lactams, along with other antimicrobials, 
face resistance from bacteria. Bacterial resistance to β-lactams was already becoming 
problematic within a few years of the introduction of penicillin in the clinic (4). Microbes 
have evolved several mechanisms to overcome antibiotic treatment. Gram-positive 
bacteria have developed penicillin-binding proteins that no longer recognize β-lactams, 
while Gram-negative bacteria can utilize β-lactamases, a class of enzymes similar to 
transpeptidases, but with the ability to hydrolyze the antibiotic from the active site 
nucleophile. Additionally, bacteria can become impermeable to the drugs or actively 
transport them away out of the cell; both strategies effectively lower the concentration of 
the antibiotic near the desired target. (2) The spread of resistance is increasingly alarming 
and some infections are becoming virtually untreatable, hastening the need for new and 
effective therapeutics. 
 
Thienamycin and the Carbapenems 
 Though not completely able to overcome bacterial resistance, the carbapenems 
are often immune to clinically-relevant β-lactamases, making them critical antibiotics (4). 
Indeed, the paradigm naturally-occurring carbapenem thienamycin is “one of the most 
potent, broad- spectrum, non-toxic antibacterial compounds ever discovered” (7). 
6	  
Thienamycin was isolated in the late 1970s from Streptomyces cattleya (8). While 
a sulfur atom is not present in the 5-member ring, the numbering convention still places 
carbon-1 in the same location, as depicted in Figure 1.4. Instead, thienamycin and related 
carbapenems contain a sulfur side chain at C2. Additionally, they possess trans 
stereochemistry across C5 and C6 and lack an amide bond in the C6 side chain, unlike 
penicillin (9). Thienamycin itself is chemically unstable, thus the N-formimidoyl analog 
(Imipenem) is used clinically (4). This drug is co-administered with cilastatin to prevent 
degradation by a mammalian dehydropeptidase in the kidney. Other carbapenems, such 
as Meropenem, have been synthesized that are resistant to the peptidase due to the 
presence of a 1-β-methyl group at C1 (See Figure 1.4). Clinically, carbapenems can be 
used to treat infections from several Gram-negative and Gram-positive bacteria. (4) 
Production and Biosynthesis: Thienamycin 
Unlike other β-lactam antibiotics, clinical carbapenems are made by total 
synthesis because thienamycin is not chemically stable, S. cattleya fermentation titers are 
low, and the host producer is difficult to manipulate genetically (4). A synthetic route of 







































Figure 1.4: Thienamycin and related clinical carbapenems. 
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itself. As an example, a 500 mg dose of Meropenem can cost around $39, while a 500 mg 
dose of Amoxicillin, a penicillin, costs around $0.14 (10). Outside the clinic, one 
common vendor sells 5 grams of Amoxicillin for $40, while 250 mg of Imipenem costs 
around $230 (11). Additional biosynthetic understanding could benefit development of a 
semi-synthetic route of production and a corresponding decrease in cost.  
 Biosynthetically, early labeling studies supported that glutamate was the source of 
the pyrroline ring in thienamycin and that C6 and C7 of the β-lactam ring were derived 
from acetate (9). Furthermore, labeled methionine experiments indicate that the carbons 
and hydrogens in the C6-ethyl side chain originate from the S-methyl of this amino acid. 
The isolation of a thienamycin co-metabolite northienamycin, which contains a C6-
hydroxylmethyl side chain, suggests that the C8 and C9 carbons are added in stepwise 
fashion to the core structure. (9) It was also observed that CoII and cobalamin increased 
carbapenem titers in cultures of producing strains (9), though it is not intuitively obvious 
why these cofactors aid production. Regarding the C2 side chain, 14C or 35S-cystine was 
fed to S. cattleya and incorporation was greater than 70% of the theoretical maximum. 
Labeled cystamine and 35S-pantethine were found to be incorporated at much lower 
levels (9). Collectively, these experiments suggested that cysteine is the source of the C2 
side chain of thienamycin. Interestingly, however, the OA-6129 series of metabolites, 
which contain a pantetheinyl moiety at C2, have also been isolated from carbapenem 
producers, suggesting that side chains longer than cysteine could play roles in 
carbapenem biosynthesis (12). One possible explanation that is consistent with all of 
these observations involves the utilization of coenzyme A (CoA, see Figure 1.5).  
8	  
In CoA biosynthesis, pantothenic acid (Vitamin B5) is phosphorylated by the 
kinase PanK. Next, an amide bond is formed with cysteine, followed by a 
decarboxylation of the cysteinyl moiety, giving 4’-phosphopantetheine. Finally, two 
enzymes PPAT and DPCK attach adenosine monophosphate (AMP) and the 3’-ribose 
phosphate, respectively, to form CoA. (13) Importantly, cysteine is used to make CoA, so 
if a CoA metabolite were used in carbapenem biosynthesis, it would rationalize the 
labeling experiments as well as the presence of OA-6129 products with the extended C2 
side chains. 






































Through sustained efforts, several steps in carbapenem biosynthesis have been 
determined, though much still remains to be elucidated. The simplest carbapenem (see 
Figure	  1.6) is produced in Pectobacterium carotovorum, rather than in actinomyces (14).  
Three enzymes are able to build the antibiotic from primary cellular metabolites (15).  
The first enzyme CarB utilizes L-pyrroline-5-carboxylic acid 1 and malonyl-CoA to give 
carboxymethylproline 2.  Using ATP, the second enzyme CarA forms the β-lactam ring, 
giving the (3S,5S)-carbapenam 3. (14, 15) Finally, the nonheme iron α-ketoglutarate-
dependent oxygenase performs an epimerization and desaturation to form the simple 
carbapenem 4 (15). 
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ThnK, L, P?
	   10	  
 Technical difficulties manipulating the producing strain S. cattleya prevented 
analysis of the thienamycin gene cluster for over 20 years.  However, in 2003 Núñez, 
Salas, and coworkers obtained the cluster, which was initially thought to contain 22 genes 
thnA through thnV (16). It was later determined that ThnU was actually involved in 
cephamycin C biosynthesis and is no longer thought to be a part of the cluster (17). 
Additional insight into the thienamycin cluster came more recently when sequence 
analysis of a related gene cluster in Streptomyces argenteolus revealed that homologs of 
thnA-thnD, thnV, and cphU (thnU) were not present with the other S. argenteolus 
carbapenem genes (18). Thus, it appears that the thienamycin gene cluster actually begins 
with thnE and ends with thnT.  
 Biochemical experiments support that the early steps of thienamycin biosynthesis 
parallel those of the simple carbapenem 4.  ThnE performs the same three coupled 
reactions as CarB and, like CarA, ThnM is able to make the (3S,5S)-carbapenam 3 (14), 
as shown in Figure	  1.6. From this point, the pathways diverge. The thienamycin cluster 
contains two putative nonheme iron, α-ketoglutarate-dependent oxygenases, which could 
potentially perform chemistry similar to CarC. However, ThnQ has been shown to install 
the hydroxyl group at C8 and ThnG is able to oxidize the C2 side-chain of thienamycin 
(19).  Interestingly, a ThnG knockout strain is still able to produce thienamycin, 
suggesting that the enzyme does not play a role in the biosynthesis of this antibiotic (20).  
 Additional biochemical studies have shown that ThnR, ThnH, and ThnT truncate 
coenzyme A, phosphopantetheine, and pantetheine, respectively, to ultimately afford the 
cysteamine side chain present in thienamycin (see Figure	  1.6), while ThnF is able to 
acetylate the cysteamine side chain (21).  The identity of the thiol that is added to the 
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carbapenam(em) nucleus is not known, nor is it clear what the timing of the truncations is 
with respect to other biosynthetic events. Efforts were made to probe stereochemical 
preferences of the truncation enzymes by making several carbapenams(ems) with various 
C2 side chains, though most of the enzymes appeared to be nonspecific (22). ThnH, 
however, was the exception, preferring that the C2-C3 double bond be present before 
removing the phosphate from phosphopantetheine.  The enzyme, however, was 
seemingly indifferent to the stereochemistry at the bridgehead position (22). Curiously, 
both ThnT and ThnR knockout strains still produce thienamycin, though this may 
indicate that some other enzymes are able to complement their function (20). While 
initial feeding experiments were interpreted to suggest that the sulfur-containing side 
chain was derived from cysteine, the presence of the truncation enzymes in the cluster 
supports the addition of a CoA-derived thiol. 
 Of the remaining genes in the cluster, thnI, thnJ, and thnS are likely involved in 
regulation, transport, and self-resistance, respectively (16). Thus, there are 5 remaining 
enzymes encoded in the cluster without assigned functions (ThnN, O, K, L, and P) and 
several remaining biosynthetic transformations including attachment of the C2 and C6 
side chains, bridgehead epimerization, and desaturation (Figure	  1.6). Gene knockout 
analyses indicate that all 5 enzymes are essential for carbapenem production (18, 20). 
Additional crossing-feeding experiments between secretor-convertor pairs suggest an 
ordering of N, O, L, P in the pathway (20), though the placement of ThnK is not known. 
While ThnN and ThnO have not been shown to have clear functions, sequence homology 
suggests that they could be involved in the formation of L-pyrroline-5-carboxylic acid 1, 
placing them early in the biosynthetic pathway (23). ThnK, ThnL, and ThnP by sequence 
12	  
analysis are thought to be cobalamin-dependent radical S-adenosylmethionine (RS) 
enzymes and are all annotated as class B RS methylases (24).  Biosynthetic studies of the 
C6-hydroxyethyl side chain in thienamycin imply that a functional methylase(s) is 
present in the pathway and ThnK, L, and P would be likely candidates. If these three 
enzymes do utilize cobalamin, it would offer a rational explanation as to why feeding this 
cofactor leads to increased production of carbapenems in Streptomyces hosts. 
RS Enzymes 
RS enzymes, including ThnK, ThnL, and ThnP, were identified by the presence of 
a Cx3Cx2C motif, which is responsible for coordinating a [4Fe-4S] cluster (25).  The 
[4Fe-4S]1+ oxidation state is thought to be required for activity and a reducing agent, such 
as dithionite, is required for in vitro reactions. Unfortunately, exposure to oxygen (for 
example, during a routine protein purification) can degrade the cluster and render the 
enzyme inactive. (25) Thus, comprehensive work with these enzymes requires the use of 
an anaerobic chamber.  
Work on this enzyme class began over 45 years ago with lysine 2,3-aminomutase 
(LAM), which converts the α-amino acid lysine into a corresponding β-amino acid (26) 












Figure 1.7: Activity of lysine 2,3-aminomutase. 
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This enzyme requires the cofactor pyridoxal-5’-phosphate and dithionite and 
activity was increased upon the addition of iron. The protein was sensitive to the presence 
of oxygen. At the time, it was intriguing that the protein also required a S-
adenosylmethionine (SAM) cofactor (26). The enzyme class is now understood to use the 
[4Fe-4S] cluster to reductively cleave a molecule of SAM to form a 5’-deoxyadenosyl 
radical (Figure 1.8), the same radical formed in adenosylcobalamin-utilizing (vitamin 
B12) reactions (25).  
This high-energy primary radical species can initiate many diverse reactions 
including rearrangements, cyclizations, sulfur-insertions, and methylations by abstracting 
a hydrogen atom from a substrate (25). If SAM is used stoichiometrically, then the 
enzyme produces 5’-deoxyadenosine (5’-dA) and methionine as SAM-derived 
coproducts. 
The presence of the C2-sulfur-containing side chain in thienamycin suggests that 




















































Figure 1.8: Reductive cleavage of SAM by an [4Fe-4S] cluster, modeled from (30). 
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enzymes; for example, biotin synthase is known to convert dethiobiotin into biotin (25). 
Many studies on biotin synthase now support a mechanism whereby a second [2Fe-2S] 
cluster is cannibalized by the enzyme and provides the source of the sulfur atom (25). A 
CoA-derived side chain, not elemental sulfur, would provide the source of the C2-
thioether in thienamycin, so it is unclear whether a second cluster would be required in 
this case. 
 There is likely at least one RS methylase in the thienamycin cluster as well. To 
date four classes of RS methylases have been described, termed Classes A, B, C, and D 
(27). The Class A methylases, exemplified by RlmN and Cfr, have two additional 
conserved cysteines, one of which is methylated as an intermediate. These enzymes 
methylate sp2-hybridized carbons, such as C2 or C8 of adenosine. (27) In contrast, the 
Class B methylases are identified by a putative N-terminal cobalamin (Cbl)-binding 
domain and thought to use methyl-Cbl (Me-Cbl). Descriptions of the characterized 
members of this class are included below. Class C enzymes have a domain similar to the 
RS protein HemN and also methylate sp2-hybridized carbons, but lack the conserved 
cysteine residues contained in Class A members. Finally, instead of using additional 
SAM for methyl group addition, Class D enzymes appear to use 
methylenetetrahydrofolate. (27)  
 The cobalamin-dependent RS enzymes, including ThnK, ThnL, and ThnP, form 
the most diverse class of RS methylases as they can methylate both carbon and 
phosphorus atoms and at multiple hybridization centers.  The first in vitro 
characterization of a Class B enzyme was carried out with PhpK from Kitasatospora 
phosalacinea and it was shown to methylate a phosphinate intermediate in bialaphos 
15	  
biosynthesis (28) (Figure 1.9B). The protein was insoluble and required solubilization 
and refolding as well as anaerobic reconstitution of the [4Fe-4S] cluster. Upon the 
addition of SAM, dithionite, substrate, and Me-Cbl, it was possible to follow the reaction 
by NMR.  Using 13C-labeled Me-Cbl, the authors showed that Me-Cbl is used as the 
source of the methyl group. (28) 
Following this work, TsrM was demonstrated to be a tryptophan-methylase (29), 
as shown in Figure 1.9C. TsrM was isolated as soluble protein and, interestingly, worked 































































better without dithionite present and did not produce 5’dA, but only S-
adenosylhomocysteine (SAH), demethylated SAM, a by product seen with classical 
SAM-dependent methylases (Figure 1.10).  The production of SAH was not dependent on 
the presence of the [4Fe-4S] cluster (29). 
While this work also supported a Me-Cbl intermediate, TsrM is likely 
mechanistically distinct from other members of the class since it does not appear to use 
the canonical 5’-deoxyadenosyl radical intermediate (29).  More recently, Liu and 
coworkers demonstrated that GenK performs a methylation in gentamicin biosynthesis 
(as shown in Figure 1.9D) (30).  Like PhpK, GenK was isolated from inclusion bodies, 
refolded, and reconstituted anaerobically.  Dithionite was found not to be useful with 
GenK (it was speculated to be due to interference by the SO2- ion with the cobalt), but 
instead the researchers employed a combination of methyl viologen and NADPH. The 
enzyme produced a 1:1 ratio of SAH and 5’-dA, which implied the utilization of two 
molecules of SAM per methylation.  The work also supported a Me-Cbl intermediate in 
the enzymatic mechanism.  
Overall, it is thought that many Class B methylases, like GenK, utilize one 
molecule of SAM as the methyl donor, which yields a methyl group to the cobalamin. A 























Figure 1.10: Traditional methylases use SAM as a methyl donor, producing SAH. 
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abstracts a hydrogen atom, forming a substrate radical. This new radical then reacts with 
methyl-cobalamin, resulting in a methylation of the substrate. (24) This reaction sequence 
is summarized in Figure 1.11. Other examples of Class B members have also been 
characterized (31-33), albeit in less detail. More work is needed with members of Class B 
to ascertain the generality of the proposed mechanism within the family. 
Thesis Goals: 
Once the thienamycin gene cluster became known, the presence of three putative 
cobalamin-dependent RS enzymes was an oddity, considering that only two carbons are 
present in the C6-hydroxyethyl side chain.  Since all three enzymes are required to make 
carbapenems (18, 20), it is highly probable that at least one of the enzymes has a non-
methylase function, which would be unprecedented for the enzyme family. Furthermore, 
it was possible that these three enzymes perform all of the remaining steps in the 
biosynthesis (C2, C6 side chain attachment, epimerization, desaturation, see Figure	  1.6).  
Thus, the activities of ThnK, ThnL, and ThnP were of paramount interest both for their 
unknown roles in the biosynthesis of an important antibiotic and for their potentially 
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Figure 1.11:  Proposed mechanism of many Class B RS methylases, (modeled from 
(24)). 
	   18	  
 The overall goal of this dissertation is to illuminate the unknown central steps of 
thienamycin biosynthesis by deciphering the chemical transformations performed by the 
triad of RS enzymes. This objective faced multiple challenges. First, the ordering of the 
enzymes and their respective substrates was largely unknown. To address these 
questions, a library of potential carbapenam substrates was synthesized as will be 
described. Secondly, the enzymes themselves suffer from low solubility and high 
sensitivity to oxygen. Efforts were taken to obtain soluble, active RS proteins, both from 
in vitro and in vivo systems, and will also be delineated. Collectively, the combination of 
biochemical and synthetic strategies applied has advanced our understanding of the roles 
of the RS enzymes in thienamycin biosynthesis. 
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Chapter 2 
 
Synthesis of Potential Substrates and Product Standards for 




 The synthesis of a variety of possible substrates and product standards was 
undertaken to provide a library to screen against the thienamycin RS enzymes. The first 
desired compound was the only known intermediate in thienamycin biosynthesis, the 
(3S,5S)-carbapenam 3, which is the product of ThnE and ThnM (1). If methylation were 
the next step after bicycle formation, then C6-methyl and ethyl variations of 3, 
compounds 8 and 9, respectively, could also be intermediates. Alternatively, C2-thioether 
formation could precede methylation. A few possible thiols could be attached to the core 
structure by an unknown enzyme. For the library, we selected a pantetheinyl C2 side 
chain that matches the OA-6129 series of isolated natural carbapenems (2). Earlier work 
in the Townsend lab also suggested that at least one late-stage enzyme (ThnQ) functions 
with a C2-pantetheinyl group (3). Furthermore, pantetheine represents an intermediate 
length of possible thiols ranging from CoA to cysteamine (4). To assess possible 
enzymatic stereochemical preferences, both pure C2-diastereomers 10 and 11 were 
desired. In case C5-epimerization occurs early in the pathway, the C5-diastereomer of 10 






Results and Discussion 
Synthesis of Compounds 3, 8, and 9 
The (3S,5S)-carbapenam 3 had been previously synthesized in the Townsend lab 
by C.J. Hastings and others following previously described procedures (5) and did not 
need to be generated for the RS experiments. A route based on the work of Ohta et al. (6) 
was employed (Figure 2.2) to make compounds 8 and 9. In their paper, the authors began 
with L-pyroglutamic acid to make a carbapenem with the “antibiotic” bridgehead. We 
desired the opposite “non-antibiotic” bridgehead and thus began with D-pyroglutamic 
acid 13. This compound was protected with benzyl bromide and benzyl chloroformate, 
sequentially.  The desired protected material 14 was purified by recrystallization from hot 
ethyl acetate/hexanes (~80% yield).  Next, either tert-butyl propionate 15 was needed to 
provide a C6-methyl group or tert-butyl butyrate 16 for a C6-ethyl group. While 15 is 

































































Figure 2.1: Synthetic targets for probing RS activity. 
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butoxide.  The resulting oil was purified by vacuum distillation to yield a clear oil. The 
enolate of either 15 or 16 was reacted with compound 14 to provide compounds 17 and 
18, respectively, in approximately 70% yield. A reductive amination using palladium on 
carbon under a hydrogen atmosphere cyclized the five-member ring, generating 19 
(methyl) or 20 (ethyl). Each of these products is a mixture of diastereomers at the site 
where the methyl or ethyl group is attached. During the reductive amination, the 
carboxylic acid directs the desired stereochemistry at what will become C5 in the 
carbapenam.  A Boc protection followed by a PNB protection formed 21 and 22. These 
compounds were deprotected by removing the Boc and tert-butyl groups. A coupling 
reaction with N,N'-dicyclohexylcarbodiimide (DCC) produced the carbapenams 23 and 
24 in greater then 80% yield. The ratio of the C5-C6 trans isomer to the cis isomer is 
approximately 1:2 (6). These diastereomers are not separable by silica chromatography. 
Treatment with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and mild heating selectively 
isomerized at the α-position (C3) to the protected carboxylic acid, forming carbapenams 
25-28. This reaction was a departure from the Ohta synthesis and was inspired by the 
observation by Bateson et al. that endo-esters at C3 in carbapenams can be isomerized to 
exo using DBU (7). The isomerization can be monitored by 1H-NMR in acetonitrile-d3 
(Figure 2.3). The doublet corresponding to the C8 methyl hydrogens in 23 (~ 1 ppm) has 
a diagnostic chemical shift depending if the C5-C6 orientation is cis or trans (Figure 2.3).  
Both of these doublets shift during the C3-epimerization.  
25	  
	  
Additionally, the resonances corresponding to the C3 hydrogens overlap for the 
cis and trans diastereomers in 23; however, both signals shift downfield (to 4.4 ppm) and 
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resolve during isomerization, resulting in the trans diastereomer 25 triplet being more 
downfield than the cis 27 triplet by ca. 0.06 ppm. The C6-diastereomers (25 and 27 or 26 
and 28) were then separable by silica gel chromatography, with the C5-C6 cis isomer 
eluting first (6). The two isomers can be distinguished by the coupling constant between 
H5 and H6 (cis: ~5.5 Hz, trans: ~2 Hz). To generate the final deprotected carbapenams 8 
and 9, the PNB-protected cis compounds 27 and 28 were hydrogenated in THF/0.5 M 
potassium phosphate buffer. A desalting column with HP-20 was needed to remove 
excess buffer. 
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Synthesis of Compounds 10-12 
 To synthesize the C-2 substituted carbapenams 10-12, a route was based on 
previously described strategies (8, 9) and further developed by K.A. Moshos (3, 10) in 
the Townsend lab (Figure	  2.4). The synthesis began with the relatively inexpensive 
precursors, sorbic acid 29 and menthol 30, which were coupled using DCC to give the 
ester 31. The diene 31 was isomerized using lithium diisopropylamide (LDA) whereupon 
the resulting terminal double bond was reacted with an isocyanate, yielding the β-lactam 
32 as a mixture of diastereomers. The diastereomers were separated by fractional 
crystallization from diethylether in which the S-isomer 33 was less soluble. 33 can be 
recrystallized to good optical purity from ether (mp: 129-132 °C, lit: 125-128 °C, (9)). 
The diastereomer 34 can be removed from the mother liquor by the addition of pentanes, 
although it typically contains residual 33. Additional recrystallizations beyond the 
procedures of Ueda et al. and Moshos were employed to help address this contamination. 
Compound 34 was recrystallized from MeOH/water using approximately 20 mL MeOH 
per gram of 34 (mp: 78.5-80 °C, lit: 77.5-78.5 °C, (9)). Another isomerization using 1,4-
diazabicyclo[2.2.2]octane (DABCO) gives 35, which was reacted with the hydrated 
aldehyde 36. The PNB-glyoxylate 36 was generated from PNB-protected tartaric acid, 
which was oxidatively cleaved using periodic acid. Reaction with thionyl chloride 
followed by the addition of triphenyl phosphine resulted in the formation of the ylide 37. 
Reductive ozonolysis (dimethylsulfide) gave the corresponding aldehyde. Upon basic 
work-up, an intramolecular Wittig reaction ensued to give the carbapenem 38.  
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The enantiopurity of 38 can be assessed by chiral HPLC (Pirkle covalent (R,R) 
Whelk-01 5100, 50% ACN/H2O, 267 nm); a slight difference (ca. 0.5 min) in retention 
time between 38 and its enantiomer 40 was observed (Figure 2.5). Unfortunately, a single 
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MeOH/H2O recrystallization of 34 did not lead to a significant increase in purity of 38 
when compared to a sample that was not recrystallized (Figure 2.5). Further 
recrystallization(s) in principle should achieve the goal. 
With 38 (or its enantiomer 40) in hand, the desired thiol, pantetheine in this case, 
was attached in a β-addition to the carbapenem. This reaction resulted in the formation of 
several of the possible stereoisomers at C2 and C3. On the basis of previous 
stereochemical analyses (7) and Nuclear Overhauser Effect (n.O.e.) NMR experiments 
performed by K. A. Moshos (3), the isomer with the H3 doublet farthest downfield as 
assessed by 1H-NMR (~4.8 ppm) has the cis-exo stereochemical relationship (Figure 2.6). 
The other main isomer observed from the pantetheine addition (H3 doublet at ~4.4 ppm) 
was assigned by Moshos to have the trans-endo thioether stereochemical relationship. 
This assignment and corresponding chemical shift is consistent with the report of Bateson 




























Figure 2.5: Chiral HPLC analysis of compound 38. 
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et al. where N-acetylcysteamine (SNAC) was added to a carbapenem instead of 
pantetheine (11). Another isomer corresponding to the cis-endo stereochemistry can also 
be observed depending on the conditions (7). 
Hydrogenation of 39 followed by a desalting column gave 10 and 11 as a mixture. 
Moshos was able to generate the diastereomer 12 with the inverted bridgehead using the 
same approach, but using 33 in lieu of 34 at the appropriate step (3, 10). To isolate 10 and 
11 individually, the compounds were separated using preparative HPLC (C18, 25% 


















Figure 2.7: HPLC separation of 10 and 11. 
























Additional Synthetic Targets 
After the initial library including 3 and 8-12 was completed and tested in vitro, it 
became clear that additional potential substrates/product standards were needed. The first 
set of compounds to be generated (41-43) contained both a C2-pantetheinyl moiety, 
matching 10-12, and an alkyl group at C6 (Figure 2.8). The second set of molecules (44-
49) was designed to probe various C2 side chains. In addition to 10 and 11 with a C2-
pantetheine, which had been synthesized previously, we sought to prepare analogs 
bearing SNAC, phosphopantetheine, or coenzyme A at C2. 
Synthesis of C2- and C6-Substituted Compounds 41-43
To generate 41 and 43, a previously used strategy (6) was initially employed (see 








































































































Figure 2.8: Additional synthetic targets for probing RS activity. 
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methyl ester giving 50 and 51 (Figure 2.9). From this point, a route similar to the PNB-
ester analogs was used to make the C5-C6 cis-carbapenams 56 and 57.  
Next, phenylselenation followed by an oxidative elimination afforded the 
carbapenems 60 and 61 in a manner similar to that previously described (6). Pantetheine 
can be added into the double bond to generate the C2 side chain in 62 and 63. Two 
C2/C3-stereoisomers were observed and assigned to be the cis-exo and trans-endo 
thioethers based upon the stereochemical analysis carried out with 39, the analogous 
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molecule lacking a C6 side chain (see Figure 2.6). Saponification with lithium hydroxide 
yielded 41 and 43. Some enrichment of each stereoisomer of 41 (41a trans-endo 
thioether, 41b cis-exo) was achieved using HPLC. The analog of 41 having a trans C6-
methyl (42) was prepared as a racemate by Moshos using a route similar to that shown in 
Figure	  2.4 (3, 10).  
Synthesis of C2-Substituted Compounds 44-49 
To prepare the additional C2-substituted compounds, the carbapenem 38 was 
again utilized. SNAC was added into 38 using 0.1 eq of DBU, as described by Moshos 
(3), to yield 64. It was discovered that CoA itself could be also be added directly into the 
carbapenem using similar conditions to those employed for the pantetheine addition. 
Hydrogenation followed by HPLC purification of the C2-diastereomers resulted in the 
desired CoA-(48 and 49) and SNAC-(44 and 45) containing compounds from the 
corresponding esters (Figure 2.10). Typical HPLC traces for the separation of 44/45 and 
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48/49 are shown in Figure 2.11. To produce the C2-phosphopantetheine derivatives 46 
and 47, the pantetheinyl compounds 10 and 11 were incubated with PanK (CoaA), a 
native CoA biosynthetic enzyme (12), and ATP as described previously (13). This 
enzymatic strategy for forming a phosphopantetheine moiety has been used previously in 
the Townsend lab (3) and experimental details are provided in the Materials and Methods 




































Figure 2.11: HPLC separation of 44/45 and 48/49. 
The top trace (red) shows the separation of the C2-SNAC compounds, 44 and 45 
(Conditions: C18, 18% MeOH/82% 10 mM K2PO4 pH 6.65, 210 nm). 
The bottom trace (blue) shows the separation of the C2-CoA compounds, 48 and 49 
(Conditions: C18, 13% MeOH/87% 10 mM K2PO4 pH 6.65, 254 nm). Since the PNB-
protected CoA-carbapenam is not purified prior to hydrogenation due to degradation on 
silica, the HPLC traces typically contain contaminants. The correct peaks are initially 
identified by High-Resolution-MS.  
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Conclusions 
 
 To probe the function of the thienamycin RS enzymes, a chemical library of 
potential substrates was desired. Two general strategies were employed to generate a 
variety of C2- and C6-substituted carbapenams. For many of the C2-substituted 
compounds, the route involved reaction of a terminal olefin with an isocyanate to form 
the β-lactam. An intramolecular Wittig reaction closed the bicycle. For the C6-alkylated 
compounds, the synthetic pathway began with pyroglutamic acid and used a peptide 
coupling to install the β-lactam. The combination of approaches afforded all required 
carbapenams, enabling in vitro testing with the RS enzymes (Chapter 3). 
 
Materials and Methods 
 
 A Bruker Avance (Billerica, MA) 300 or 400 MHz spectrometer was utilized for all 
1H and 13C NMR spectra, which are reported in parts per million (δ) referenced against a 
TMS standard or residual solvent peak.  The JHU Chemistry Department Mass 
Spectrometry Facility determined exact masses by fast atom bombardment (FAB) or 
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Compounds 10, 11, 12: The C2-pantetheinyl carbapenams were made as previously 
described (3, 10). The diastereomers 10 and 11 were separated from each other and 
purified using an Agilent model 1100 HPLC equipped with a multi-wavelength 
ultraviolet–visible detector in conjunction with a reverse-phase Phenomenex Luna 10µ 
C18(2) 100 Å preparatory column (250 x 21.20 mm ID).  The mobile phase was isocratic 
25% methanol and 75% buffer (10 mM potassium phosphate, pH 6.65) at a flow rate of 5 






Compound 42: The C6-trans-methyl, C2-pantetheinyl carbapenam was prepared as a 
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Benzyl (2R)-1-carboxybenzyl-5-oxopyrrolidine-2-carboxylate (14).  
Diisopropylethylamine (54 mL, 310 mmol) was added to D-pyroglutamic acid (20 g, 160 
mmol, TCI America/AK Scientific) in dichloromethane (500 mL).  Benzyl bromide (22 
ml, 190 mmol) was added and the solution was refluxed for 4h.  The reaction mixture 
was concentrated in vacuo and the crude oil was redissolved in ethyl acetate (400 
ml).  The cloudy mixture was filtered through silica on top of Celite and the silica/Celite 
plug was washed twice with ethyl acetate (200 mL).  The eluate was concentrated in 
vacuo and redissolved in tetrahydrofuran (600 mL) to which was added lithium 
bis(trimethylsilyl)amide (155 mL, 1.0 M, 155 mmol) at -
min.  Benzyl chloroformate (30.8 mL, 202 mmol) was added and the reaction mixture 
was allowed to stir for 10 min.  The reaction was quenched with aqueous ammonium 
chloride (400 mL) and the solution was warmed to room temperature and the phases were 
separated.  The aqueous layer was extracted 5× with ethyl acetate (400 mL) and the 
combined organic fractions were washed with brine, dried with anhydrous magnesium 
sulfate, filtered, and concentrated in vacuo.  The solid crude product was recrystallized 
from hot ethyl acetate/hexanes to give 14 as white crystals (34.4 g, 63% yield). 1H-NMR 
(400 MHz; CDCl3): δ 7.36-7.28 (m, 10H), 5.22 (d, J = 1.3 Hz, 2H), 5.13 (s, 2H), 4.72 
(dd, J = 9.4, 2.7 Hz, 1H), 2.68-2.58 (m, 1H), 2.50 (ddd, J = 17.6, 9.3, 3.3 Hz, 1H), 2.34 
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δ 172.9, 170.9, 150.9, 135.10, 135.08, 128.80, 128.73, 128.69, 128.56, 128.41, 128.26, 
68.5, 67.5, 58.9, 31.1, 21.9 ppm.  HRMS (FAB) m/z:  [M+H]+ calcd. for C20H19NO5 









oxoheptanedioate (17).  This synthesis was adapted from the procedures of Ohta et al. 
(6).   A solution of lithium diisopropylamide in tetrahydrofuran (17 mL, 2.0 M, 34 mmol) 
was added to a solution of tert-butyl propionate (4.3 ml, 28 mmol) in tetrahydrofuran 
(300 mL) at - 14 in tetrahydrofuran 
(40 mL) was added slowly to the reaction mixture.  After stirring for 30-60 min at -
the reaction was quenched with saturated ammonium chloride and the phases were 
separated.  The aqueous layer was extracted three times with dichloromethane (50 
mL).  The combined organic layers were washed with brine, dried with anhydrous 
magnesium sulfate, and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography using 25% ethyl acetate in hexanes to give 17 (9.9 g, 72%) as a colorless 
oil, which solidified overnight at room temperature. TLC (ethyl acetate:hexanes, 2:3 v/v): 
Rf = 0.75; 1H-NMR (400 MHz; CDCl3): δ 7.35 (s, 10H), 5.30-5.46 (m, 1H), 5.17 (s, 2H), 
5.09 (s, 2H), 4.31-4.47 (m, 1H), 3.34-3.36 (m, 1H), 2.47-2.73 (m, 2H), 1.94-2.22 (m, 
2H), 1.42 (s, 9H), 1.23 (bd, J = 6.8 Hz, 3H) ppm; 13C NMR (101 MHz; CDCl3): δ 205.2, 
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67.2, 53.9, 53.6, 37.3, 28.0, 26.4, 12.8 ppm; HRMS (FAB) m/z:  [M-OH]+ calcd. for 








tert-Butyl butyrate (16).  Conditions were modeled after a similar reaction 
(http://orgprepdaily.wordpress.com/2007/07/25/2-chloro-5-iodobenzoic-acid-tert-butyl-
ester/. [Accessed 09 April 15]). Butyryl chloride (20 mL, 190 mmol) in tetrahydrofuran 
(40 mL) was added to a slurry of tetrahydrofuran (400 mL) and potassium tert-butoxide 
(23.4 g, 209 mmol) at 0 
temperature.  Silica gel (76 g, 1.3 mol) and distilled water (1.14 mL, 62.6 mmol) were 
added and allowed to stir 20 min.  Slurry was filtered through silica gel and concentrated.  
A yellow oil (18 g, 66%) was isolated.   The crude product was purified by vacuum 
distillation (heating at 35-
1H-NMR (400 MHz; CDCl3): δ 2.18 (t, J = 7.4 Hz, 2H), 1.61 (sext, J = 7.4 Hz, 2H), 1.44 
(s, 9H), 0.93 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (101 MHz; CDCl3): δ 173.3, 80.0, 37.6, 








7-Benzyl 1-tert-butyl (6R)-6-(benzyloxycarbonylamino)-2-ethyl-3-oxoheptanedioate 
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was purified by silica gel chromatography using ethyl acetate/hexanes (3:20) to give the 
titled product (56%) as an oil, which solidified to a white solid. TLC (ethyl 
acetate:hexanes, 2:3 v/v): Rf = 0.69; 1H-NMR (400 MHz; CDCl3): δ 7.34 (bs, 10H), 5.40-
5.34 (m, 1H), 5.16 (s, 2H), 5.09 (s, 2H), 4.42-4.36 (m, 1H), 3.21-3.16 (m, 1H), 2.64-2.48 
(m, 2H), 2.20-1.90 (m, 2H), 1.81-1.73 (m, 2H), 1.42 (s, 9H), 0.89-0.85 (m, 3H) ppm; 13C 
NMR (101 MHz; CDCl3): δ 204.7, 171.87, 171.85, 168.9, 156.0, 136.2, 135.3, 128.75, 
128.62, 128.43, 128.29, 128.19, 82.01, 81.97, 67.4, 67.2, 61.7, 53.57, 53.51, 37.71, 37.61, 
28.0, 26.44, 26.31, 21.6, 12.0 ppm; HRMS (FAB) m/z:  [M+H]+ calcd. for C28H35NO7 






(2R,5S)-5-(1-(tert-Butoxy)-1-oxopropan-2-yl)pyrrolidine-2-carboxylic acid (19). This 
synthesis was adapted from the procedures of Ohta et al. (6).   Palladium on carbon (0.4 
g, 8% w/w) was carefully added to a solution of 17 (5 g, 10 mmol) in acetic acid (1 mL) 
and ethanol (40 mL) in a bomb flask. The reaction mixture was pressurized to 50 psi with 
hydrogen gas in a Parr-shaker apparatus and shaken for 16 h.  The reaction mixture was 
then filtered over Celite and concentrated in vacuo.  The as-isolated product is a thick 
foam/oil (near quantitative yield).  TLC (methanol:acetonitrile, 3:7 v/v): Rf = 0.19; 1H-
NMR (400 MHz; CDCl3): δ  4.05 (t, J = 6.8 Hz, 1H), 3.77-3.59 (m, 1H), 2.85-2.74 (m, 
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7.1 Hz, 2H), 1.27 (d, J = 7.3 Hz, 1H) ppm; 13C NMR (101 MHz; CDCl3): δ 173.56, 
173.52, 172.6, 172.0, 82.33, 82.23, 62.3, 61.4, 60.8, 60.4, 42.5, 42.3, 29.2, 29.0, 28.3, 
28.04, 28.01, 27.7, 15.4, 14.4 ppm; HRMS (ESI) m/z:  [M+H]+ calcd. for C12H21NO4  






(2R,5S)-5-(1-(tert-Butoxy)-1-oxobutan-2-yl)pyrrolidine-2-carboxylic acid (20).  
Reaction with compound 18 was conducted as described above for 19.  The product is a 
foam (near quantitative yield), which solidified.  TLC (methanol:acetonitrile, 3:7 v/v): Rf 
= 0.18; 1H-NMR (400 MHz; CDCl3): δ 4.08 (t, J = 6.1 Hz, 1H), 3.82-3.63 (m, 1H), 2.64-
2.53 (m, 1H), 2.31-2.20 (m, 2H), 2.05-2.00 (m, 1H), 1.86-1.69 (m, 2H), 1.69-1.57 (m, 
1H), 1.51-1.43 (m, 9H), 0.97 (t, J = 7.2 Hz, 3H) ppm; 13C NMR (101 MHz; CDCl3): δ 
173.50, 173.47, 172.4, 171.5, 82.7, 82.2, 61.3, 60.76, 60.57, 50.7, 49.4, 29.06, 28.88, 
28.3, 28.1, 23.7, 23.4, 11.61, 11.47 ppm; HRMS (ESI) m/z:  [M+H]+ calcd. for 
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The following protections (21, 22, 50, 51) result in mixtures of diastereomers/rotamers, 







yl)pyrrolidine-2-carboxylate (50).  This synthesis was adapted from the procedures of 
Ohta et al. (6). Potassium carbonate (3.5 g, 25 mmol) and sodium hydroxide (0.49 g, 13 
mmol) were added to a solution of 19 (2.0   A 
solution of di-tert-butyl dicarbonate (3.7 g, 17 mmol) in tetrahydrofuran (34 mL) was 
  
and then allowed to warm to room temperature and stirred for 16 h.  The reaction mixture 
was concentrated in vacuo, washed with diethyl ether, and acidified to pH = 2 with 
potassium bisulfate.  The solution was then extracted twice with ethyl acetate and the 
combined organic layers were washed with brine, dried with anhydrous magnesium 
sulfate, and concentrated in vacuo.  The crude residue was dissolved in 
dimethylformamide (84 mL) to which cesium carbonate (3.4 g, 11 mmol) was added and 
allowed to stir for 10 min.  Methyl iodide (1.05 mL, 16.9 mmol) was added to the 
reaction mixture dropwise and the solution was stirred for 16 h.  The reaction was 
quenched with saturated ammonium chloride, the phases separated, and the aqueous layer 
was extracted twice with diethyl ether.  The combined organic fractions were dried with 
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silica gel chromatography using ethyl acetate:hexanes (1:3) to give 50 (2.39 g, 79%) as 
an oil, which became a waxy solid overnight. TLC (ethyl acetate:hexanes, 7:13 v/v): Rf = 
0.77; (major isomer) 1H-NMR (400 MHz; CDCl3): δ 4.20 (dd, J = 19.9, 8.4 Hz, 1H), 
4.03 (app t, J = 8.2 Hz, 1H), 3.65 (s, 3H), 2.39-2.10 (m, 2H), 1.92-1.60 (m, 3H), 1.40 (s, 
9H), 1.36 (s, 9H), 1.16 (d, J = 7.0 Hz, 3H) ppm; (minor isomer) 1H-NMR (400 MHz; 
CDCl3): δ 4.24-4.16 (m, 1H), 4.13-4.08 (m, 1H), 3.65 (s, 3H), 2.39-2.10 (m, 2H), 1.92-
1.60 (m, 3H), 1.40 (s, 9H), 1.36 (s, 9H), 1.03 (d, J = 7.2 Hz, 3H) ppm; (major isomer) 13C 
NMR (101 MHz; CDCl3): δ 173.5, 173.0, 153.6, 79.6, 79.1, 59.3, 59.1, 51.5, 44.7, 27.7, 
27.4, 25.3, 14.7 ppm; (minor isomer) 13C NMR (101 MHz; CDCl3): δ 173.1, 172.8, 
153.6, 79.4, 79.1, 59.8, 59.3, 51.3, 44.7, 27.7, 27.4, 23.3, 9.5 ppm; HRMS (FAB) 







yl)pyrrolidine-2-carboxylate (51).  Reaction with compound 20 was conducted as 
described above.  The crude oil was purified by silica gel chromatography using 20% 
ethyl acetate in hexanes to give 51 (73%) as an oil.  TLC (ethyl acetate:hexanes, 1:4 v/v): 
Rf = 0.52;  (major isomer) 1H-NMR (400 MHz; CDCl3): δ 4.20 (dd, J = 16.3, 7.9 Hz, 
1H), 4.00 (m, 1H), 3.64 (s, 3H), 2.30-2.22 (m, 2H), 1.90-1.52 (m, 5H), 1.41 (s, 9H), 1.36 
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4.18 (dd, J = 16.1, 7.6 Hz, 1H), 4.00 (m, 1H), 3.64 (s, 3H), 2.15-2.07 (m, 1H), 1.90-1.52 
(m, 6H), 1.40 (s, 9H), 1.36 (s, 9H), 0.83 (t, J = 7.3 Hz, 3H) ppm; (major isomer) 13C 
NMR (101 MHz; CDCl3): δ 173.0, 172.7, 153.5, 79.7, 79.1, 59.3, 59.0, 52.4, 51.4, 28.2, 
27.6, 27.5, 25.4, 22.5, 11.5 ppm; (minor isomer) 13C NMR (101 MHz; CDCl3): δ 172.4, 
172.3, 153.5, 79.4, 59.8, 59.0, 52.4, 51.3, 28.2, 27.6, 27.5, 25.5, 22.5, 12.3 ppm; HRMS 







yl)pyrrolidine-2-carboxylate (21).  The Boc protection of 19 was conducted as 
described above for 50.  The residue (0.20 g, 0.58 mmol) was redissolved in 
dimethylformamide (6 mL) and diisopropylethylamine (0.22 ml, 1.3 mmol) followed by 
the addition of p-nitrobenzyl bromide (0.14 g, 0.64 mmol) in dimethylformamide (3 mL).  
Solution was stirred 80 min.  Saturated ammonium chloride was added to the solution 
and was extracted twice with ethyl acetate.  The combined organic layers were washed 
with brine, dried, and concentrated.  Silica gel chromatography (ethyl acetate/hexanes, 
1:4) was used to purify the oil (0.23 g, 65% over both steps).  TLC (ethyl 
acetate:hexanes, 1:4 v/v): Rf = 0.21; (major isomer) 1H-NMR (400 MHz; CDCl3): δ 8.22 
(d, J = 8.7 Hz, 2H), 7.64 (d, J = 8.7 Hz, 2H), 5.34, 5.23 (ABq, JAB = 14 Hz, 2H), 4.31 (q, 
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5.7 Hz, 1H), 1.39 (s, (H), 1.33 (s, 9H), 1.11 (d, J = 7.0 Hz, 3H) ppm; (minor isomer) 1H-
NMR (400 MHz; CDCl3): δ 8.22 (d, J = 8.7 Hz, 2H), 7.64 (d, J = 8.7 Hz, 2H), 5.34, 5.23 
(ABq, JAB = 14 Hz, 2H), 4.31 (q, J = 8.0 Hz, 1H), 4.12 (dt, J = 8.0, 4.2 Hz, 1H), 2.39-
2.28 (m, 1H), 2.21-2.14 (m, 1H), 1.98-1.84 (m, 2H), 1.79-1.73 (m, 1H), 1.39 (s, (H), 1.33 
(s, 9H), 0.99 (d, J = 7.2 Hz, 3H) ppm; (major isomer) 13C NMR (101 MHz; CDCl3): δ 
173.3, 172.1, 153.6, 147.0, 143.4, 128.3, 123.1, 79.5, 79.2, 64.5, 59.4, 59.1, 44.7, 28.8, 
27.6, 27.4, 25.0, 14.7 ppm; (minor isomer) 13C NMR (101 MHz; CDCl3): δ 173.3, 172.7, 
153.6, 147.0, 143.4, 128.3, 123.1, 79.3, 79.2, 64.5, 59.9, 59.4, 44.7, 28.8, 27.6, 27.4, 25.0, 








yl)pyrrolidine-2-carboxylate (22).  Reaction with 20 was conducted as described above.  
Multiple rounds of silica gel chromatography (ethyl acetate:hexanes, 1:19 to 3:7) were 
used to purify the product as an oil (51%).  TLC (ethyl acetate:hexanes, 1:4 v/v): Rf = 
0.35; (major isomer) 1H-NMR (400 MHz; CDCl3): δ 8.22 (d, J = 8.4 Hz, 2H), 7.63 (d, J 
= 8.5 Hz, 2H), 5.34, 5.22 (ABq, JAB = 13.6 Hz, 2H), 4.34-4.27 (m, 1H), 4.05-3.99 (m, 
1H), 2.25-2.14 (m, 2H), 1.91-1.83 (m, 2H), 1.67-1.60 (m, 2H), 1.57-1.49 (m, 1H), 1.39 
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CDCl3): δ 8.22 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.5 Hz, 2H), 5.28 (s, 2H), 4.34-4.27 (m, 
1H), 4.05-3.99 (m, 1H), 2.35-2.29 (m, 1H), 1.91-1.83 (m, 3H), 1.67-1.60 (m, 2H), 1.57-
1.49 (m, 1H), 1.39 (s, (H), 1.34 (s, 9H), 0.77 (t, J = 8.1 Hz, 3H) ppm; (major isomer) 13C 
NMR (101 MHz; CDCl3): δ 172.6, 172.1, 153.4, 147.1, 143.4, 128.4, 123.2, 79.8, 79.3, 
64.5, 59.5, 59.1, 52.4, 28.3, 27.6, 27.5, 25.5, 22.5, 11.4 ppm; (minor isomer) 13C NMR 
(101 MHz; CDCl3): δ 172.2, 172.1, 153.7, 147.1, 143.4, 128.4, 123.2, 79.4, 79.3, 64.5, 
60.0, 59.1, 52.4, 28.3, 27.6, 27.5, 25.5, 22.5, 12.2 ppm; HRMS (FAB) m/z:  [M+H]+ 
calcd. for C25H36N2O8 493.25499; found 493.25445. 
 
   
 
 
Methyl (3S,5S,6R)-6-methylcarbapenam-3-carboxylate (56).  This synthesis was 
adapted from the procedures of Ohta et al. (6).  2,6-Lutidine (1.4 mL, 12 mmol) and 
trimethylsilyl triflate (1.8 mL, 10 mmol) were added slowly to a solution of 50 (1.2 g, 3.3 
rred for 2 h.  A solution of 
hydrochloric acid in dioxane (7.7 
min.  The reaction mixture was concentrated in vacuo to yield dark red oil.  The crude oil 
was dissolved in dichloromethane (500 mL) to which diisopropylethylamine (2.6 mL, 15 
mmol) followed by a solution of N,N'-dicyclohexylcarbodiimide (0.90 g, 4.4 mmol) in 
  The mixture was allowed to slowly warm 
to ambient temperature while stirring over 23 h.  The reaction mixture was concentrated 
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washed 3 × with a cold solution of acetic acid in water (5%), dried with anhydrous 
sodium sulfate, and concentrated in vacuo.  The crude oil was purified by silica gel 
chromatography using ethyl acetate:hexanes (1:2) to give a clear oil (0.45 g, 73%).  TLC 
(ethyl acetate:hexanes, 2:3 v/v): Rf = 0.36.  1,8-Diazabicyclo[5.4.0]undec-7-ene (1.13 
mL, 7.6 mmol) was added to a solution of the mixture of diastereomers (1.38 g, 7.5 
 The reaction mixture was 
concentrated in vacuo to give a brown oil. The crude product was purified from its 
diastereomer by silica gel chromatography using ethyl acetate:hexanes (3:17) to give the 
titled compound (eluted first) as an oil (0.59 g, 43%).  TLC (ethyl acetate:hexanes, 2:3 
v/v): Rf = 0.52; 1H-NMR (300 MHz; CDCl3): δ  4.35 (t, J = 7.3 Hz, 1H), 3.96 (app q, J = 
6.3 Hz, 1H), 3.73 (s, 3H), 3.50 (qd, J = 7.7, 5.5 Hz, 1H), 2.45-2.35 (m, 1H), 2.29-2.17 
(m, 1H), 2.06-1.96 (m, 1H), 1.63 (app. ddt, J = 13.1, 9.0, 7.8 Hz, 1H), 1.13 (d, J = 7.7 Hz, 
3H) ppm; 13C NMR (101 MHz; CDCl3): δ 181.1, 172.0, 58.6, 57.7, 52.5, 45.3, 34.6, 






p-Nitrobenzyl (3S,5S,6R)-6-methylcarbapenam-3-carboxylate (27).  The coupling 
reaction was conducted as above using 21, 63% yield overall.  TLC (ethyl 
acetate:hexanes, 2:3 v/v): Rf = 0.31; 1H-NMR (400 MHz; CDCl3): δ  8.23 (d, J = 8.8 Hz, 
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12.9, 6.5 Hz, 1H), 3.52 (qd, J = 7.7, 5.6 Hz, 1H), 2.49-2.41 (m, 1H), 2.29-2.20 (m, 1H), 
2.07-1.99 (m, 1H), 1.71-1.63 (m, 1H), 1.15 (d, J = 7.7 Hz, 3H) ppm; HRMS (FAB) 
m/z:  [M+H]+ calcd. for C15H16N2O5 305.11375; found 305.11333.  The product data 






Methyl (3S,5S,6R)-6-ethylcarbapenam-3-carboxylate (57).  The coupling reaction was 
conducted as above using 51, 35% yield overall.  TLC (ethyl acetate:hexanes, 2:3 v/v): Rf 
= 0.61; 1H-NMR (300 MHz; CDCl3): δ  4.34 (t, J = 7.5 Hz, 1H), 3.95 (app dt, J = 7.5, 5.9 
Hz, 1H), 3.73 (s, 3H), 3.33 (ddd, J = 9.6, 7.4, 5.4 Hz, 1H), 2.48-2.37 (m, 1H), 2.29-2.17 
(m, 1H), 2.09-1.99 (m, 1H), 1.74-1.40 (m, 3H), 0.98 (t, J = 7.4 Hz, 3H) ppm; 13C NMR 
(101 MHz; CDCl3): δ 180.3, 172.1, 58.4, 57.2, 52.52, 52.49, 34.6, 25.3, 18.4, 12.0 ppm; 






p-Nitrobenzyl (3S,5S,6R)-6-ethylcarbapenam-3-carboxylate (28).  The coupling 
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acetate:hexanes, 2:3 v/v): Rf  = 0.38; 1H-NMR (400 MHz; CDCl3): δ  8.23 (d, J = 8.7 Hz, 
2H), 7.52 (d, J = 8.8 Hz, 2H), 5.25 (s, 2H), 4.41 (t, J = 7.5 Hz, 1H), 3.97-3.92 (m, 1H), 
3.35 (ddd, J = 9.6, 7.4, 5.4 Hz, 1H), 2.52-2.39 (m, 1H), 2.31-2.17 (m, 1H), 2.13-1.99 (m, 
1H), 1.75-1.57 (m, 2H), 1.55-1.42 (m, 1H), 0.99 (t, J = 7.4 Hz, 3H) ppm; HRMS (FAB) 
m/z:  [M+H]+ calcd. for C16H18N2O5 319.12940; found 319.12849.  The product data 





Potassium (3S,5S,6R)-6-methylcarbapenam-3-carboxylate (8).  27 (60 mg) was 
dissolved in tetrahydrofuran (4 mL) and potassium phosphate buffer (2 mL, 0.5M, pH 
7.0).  10% palladium on carbon (1:1 w/w with compound 27) was added and placed 
under hydrogen (40 psi) for 1 h with shaking.  The mixture was filtered through Celite 
and washed with water and diethyl ether.  The aqueous solution was washed with diethyl 
ether, filtered (0.2 µm, nylon), and lyophilized.  The resulting powder was desalted by 
passage through HP-20 diaion resin. 1H-NMR (400 MHz; D2O): δ 4.14 (t, J = 7.8 Hz, 
1H), 3.95 (dt, J = 8.1, 5.6 Hz, 1H), 3.50 (qd, J = 7.7, 5.1 Hz, 1H), 2.56-2.48 (m, 1H), 
2.14-2.05 (m, 1H), 2.01-1.94 (m, 1H), 1.67-1.57 (m, 1H), 1.11 (d, J = 7.8 Hz, 3H) ppm; 
HRMS (ESI) m/z:  [M-H]- calcd. for C8H11NO3 168.0661; found 168.0648.  The product 













Potassium (3S,5S,6R)-6-ethylcarbapenam-3-carboxylate (9).  28 was deprotected in a 
similar fashion to the C6-methyl analog 27. 1H-NMR (400 MHz; D2O): δ 4.12 (t, J = 7.8 
Hz, 1H), 3.96-3.91 (m, 1H), 3.38-3.32 (m, 1H), 2.58-2.50 (m, 1H), 2.11-1.96 (m, 2H), 
1.65-1.47 (m, 3H), 0.93 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (101 MHz; D2O): δ 184.8, 
180.4, 61.6, 57.9, 51.2, 36.1, 25.6, 18.3, 11.6 ppm; HRMS (ESI) m/z:  [M-H]- calcd. for 





Methyl (5S,6R)-6-methylcarbapenem-3-carboxylate (60).  This synthesis was adapted 
from the procedures of Ohta et al. (6).  A solution of lithium hexamethyl-disilazane in 
tetrahydrofuran (3.6 mL, 1M, 3.6 mmol) was added to 56 (301 mg, 1.64 mmol) in 
tetrahydrofuran (16.4 mL) at -
g, 4.93 mmol) was added at - owed to warm to room temperature over 1h.  
The reaction mixture was diluted with ethyl acetate (20 mL) and washed with water (20 
mL), brine (20 mL), dried with anhydrous sodium sulfate, filtered and concentrated in 
vacuo.  The crude residue was run through a silica plug with 20% ethyl acetate in 
hexanes to remove excess phenyl selenium bromide and then concentrated.  The resulting 
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added a solution of m-chloroperbenzoic acid (131 mg, 0.760 mmol) in dichloromethane 
(5 mL) at - -
with triethylamine (141 µL, 1.01 mmol) and diluted with dichloromethane (150 mL).  
The reaction mixture was washed twice with saturated ammonium bicarbonate (50 mL), 
brine (50 mL), dried with anhydrous sodium sulfate, filtered, and concentrated in vacuo.  
The crude residue was purified by silica gel chromatography using ethyl acetate:hexanes 
(3:7) to give 60 (52 mg, 17%) as a yellow oil. TLC (ethyl acetate:hexanes, 3:7 v/v): Rf = 
0.32; 1H-NMR (300 MHz; CDCl3): δ 6.52 (t, J = 2.8 Hz, 1H), 4.37 (ddd, J = 10.0, 8.7, 
6.2 Hz, 1H), 3.83 (s, 3H), 3.74-3.66 (m, 1H), 2.76 (app. qdd, J = 19.4, 9.4, 2.8 Hz, 2H), 
1.27 (d, J = 7.7 Hz, 3H) ppm; 13C NMR (101 MHz; CDCl3): δ 180.8, 161.3, 135.9, 
132.4, 56.1, 52.5, 47.4, 30.65, 9.9 ppm; HRMS (ESI) m/z:  [M+H]+ calcd. for C9H11NO3 






Methyl (5S,6R)-6-ethylcarbapenem-3-carboxylate (61).  57 was desaturated in a 
similar fashion to the C6-methyl analog (56) to give 61 (41 mg, 9.4%). TLC (ethyl 
acetate:hexanes, 3:7 v/v): Rf = 0.60; 1H-NMR (400 MHz; CDCl3): δ 6.51 (t, J = 2.6 Hz, 
1H), 4.35 (ddd, J = 9.9, 8.9, 6.1 Hz, 1H), 3.82 (s, 3H), 3.53 (dt, J = 9.6, 6.6, 1H), 2.82-
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NMR (101 MHz; CDCl3): δ 180.1, 161.3, 135.7, 132.3, 55.7, 54.3, 52.5, 30.9, 18.9, 11.9 




Methyl (3R,5S,6R)-6-methyl-2-pantetheinyl-carbapenam-3-carboxylate (62). 
Hydrochloric acid (471 µL, 1M) was added to pantetheine acetonide (157 mg, 0.495 
mmol, as described elsewhere(4)) in tetrahydrofuran (691 µL) and stirred for 30 min.  
Sodium hydroxide (471 µL, 1M) was then added to neutralize the reaction mixture.  The 
product pantetheine diol was directly added to 60 (64 mg, 0.35 mmol) in acetonitrile (960 
µL) to which was added triethylamine (25 µL, 0.18 mmol) and stirred for 30 min at 
ambient temperature.  The reaction mixture was diluted with ethyl acetate (15 mL), 
washed with saturated ammonium chloride (4 mL), and brine (10 mL).  The combined 
aqueous layers were extracted with ethyl acetate (15 mL) and the combined organic 
fractions were dried with anhydrous sodium sulfate, filtered, and concentrated in vacuo.  
The crude oil was purified by silica gel chromatography using ethanol:chloroform (1:9) 
to give 62 (16 mg) as an inseparable mixture of C2 diastereomers in a ratio of 7:5 
(62a:62b) by 1H-NMR. TLC (ethanol:chloroform, 1:9 v/v): Rf = 0.25; 62a: 1H-NMR 
(400 MHz; MeOD): δ  4.67 (d, J = 7.2 Hz, 1H), 4.2-4.14 (m, 2H), 3.89 (s, 1H), 3.74 (s, 
3H), 3.58-3.53 (m, 3H), 3.50, 3.36 (ABq, JAB = 14.4 Hz, 2H), 2.84-2.65 (m, 4H), 2.43 (t, 

































	   53	  
1H), 1.15 (d, J = 7.8, 3H), 0.92 (s, 6H) ppm; 62b: 1H-NMR (400 MHz; MeOD): δ 4.17 
(d, J = 6.1 Hz, 1H), 4.2-4.14 (m, 1H) 3.99 (ddd, J = 8.0, 6.5, 5.4 Hz, 1H), 3.85 (s, 1H), 
3.76 (s, 3H), 3.58-3.53 (m, 3H), 3.43, 3.29 (ABq, JAB = 11.2 Hz, 2H), 2.84-2.65 (m, 6H), 
2.43 (t, J = 5.7 Hz, 2H), 1.19 (d, J = 7.7, 3H), 0.92 (s, 6H) ppm; HRMS (ESI) 




Methyl (3R,5S,6R)-6-ethyl-2-pantetheinyl-carbapenam-3-carboxylate (63). 
The carbapenem 61 was reacted with pantetheine in a similar fashion to the C6-methyl 
analogue (carbapenem 60) to give 63 (12 mg, 13%) as an inseparable mixture of C2 
diastereomers in a nearly equal ratio by 1H-NMR.  TLC (ethanol:chloroform, 1:9 v/v): Rf 
= 0.45; 63a: 1H-NMR (400 MHz; MeOD): δ 4.60 (d, J = 7.3 Hz, 1H), 4.15-3.98 (m, 1H), 
3.83-3.78 (m, 1H), 3.81 (s, 1H), 3.71 (s, 3H), 3.48-3.26 (m, 4H),  3.43, 3.29 (ABq, JAB = 
10.8 Hz, 2H), 2.72 (dt, J = 13.0, 6.2, 1H), 2.64 (dt, J = 12.9, 6.5, 1H), 2.36 (t, J = 5.5 Hz, 
2H), 2.31-2.13 (m, 2H), 1.61-1.41 (m, 2H), 0.94 (t, J = 7.8 Hz, 3H), 0.85 (s, 6H) ppm; 
63b: 1H-NMR (400 MHz; MeOD): δ 4.08 (d, J = 6.5 Hz, 1H), 4.15-3.98 (m, 1H), 3.94-
3.86 (m, 1H), 3.82 (s, 1H), 3.67 (s, 3H), 3.49-3.60 (m, 1H), 3.48-3.26 (m, 4H), 3.43, 3.29 
(ABq, JAB = 10.8 Hz, 2H), 3.08-2.79 (m, 2H), 2.55-2.39 (m, 1H), 2.36 (t, J = 5.5 Hz, 2H), 
1.61-1.41 (m, 2H),  0.96 (t, J = 7.5 Hz, 3H), 0.85 (s, 6H) ppm;  63a and 63b: 13C NMR 
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67.3, 67.2, 59.2, 55.4, 55.3, 54.6, 54.5, 54.2, 54.1, 53.4, 53.3, 41.4, 37.5, 37.4, 37.3, 34.1, 
33.1, 22.4, 22.0, 20.7 20.3, 13.3, 13.0 ppm; HRMS (ESI) m/z:  [M+H]+ calcd. for 




Ammonium (3R,5S,6R)-6-methyl-2-pantetheinyl-carbapenam-3-carboxylate (41a, 
41b).  A solution of lithium hydroxide in water (1M, 20 µL) was added to 62 (8 mg, 
0.018 
TLC monitoring revealed incomplete reaction.  A second batch of lithium hydroxide 
with K2HPO4 (10 mM, pH = 7.0, 500 µL).  The mixture was concentrated in vacuo to 
remove the organic solvent, and immediately injected onto a preparatory reverse-phase 
HPLC (Phenomonex Luna C18(2) 250 x 21.2 mm 10 micron 100 Å, 10:90 5 mM 
NH4HCO3 in water : acetonitrile, 5 mL/min) for purification.  The C2-C3 “cis” 
diastereomer 41b eluted at 11 min and the C2-C3 “trans” diastereomer 41a eluted at 13 
min, allowing for enrichment of each diastereomer.  The compounds were collected and 
lyophilized to give carbapenams 41a (1.27 mg, 16%) and 41b (0.63 mg, 8%) as white 
powders. 41a: 1H-NMR (400 MHz; D2O): δ 4.06 (d, J = 5.4 Hz, 1H), 4.08-4.04 (m, 1H), 
3.99 (s, 1H), 3.82-3.75 (m, 1H), 3.61 (dd, J = 8.2, 5.3 Hz, 1H), 3.53-3.38 (m, 4H), 3.58, 
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1H), 2.51 (t, J = 6.3, 2H), 2.45 (dt, J = 13.9, 6.8 Hz, 1H), 1.7 (dt, J = 14.3, 7.2 Hz, 1H), 
1.20 (d, J = 7.9 Hz, 3H), 0.93 (s, 3H), 0.89 (s, 3H) ppm; HRMS (ESI) m/z:  [M+H]+ 
calcd. for C19H31N3O7S 446.1961; found 446.1957; 41b: 1H-NMR (400 MHz; D2O): δ 
4.34 (d, J = 7.3 Hz, 1H), 4.10 (dd, J = 13.5, 6.2, 1H), 3.90 (s, 1H), 3.71 (s, 1H), 3.67 (dd, 
J = 12.3, 6.4 Hz, 1H), 3.56 (dd, J = 11.9, 4.7 Hz, 1H), 3.56-3.34 (m, 3H), 3.48, 3.24 
(ABq, JAB = 11.6 Hz, 2H),  2.41 (t, J = 6.6, 2H), 2.09 (dt, J = 13.5, 6.8 Hz, 1H), 2.00 (dt, 
J = 13.4, 6.7 Hz, 1H), 1.04 (d, J = 7.7 Hz, 3H), 0.83 (s, 3H), 0.80 (s, 3H) ppm; HRMS 







Sodium (3R,5S,6R)-6-ethyl-2-pantetheinyl-carbapenam-3-carboxylate (43).  An 
analytical amount of the protected methyl ester 63 was dissolved in 1:1 acetonitrile:H2O.  
The solution was adjusted to pH ≥ 10 with NaOH (~1 M) and allowed to react at room 
temperature for 10 min.  The solution was then neutralized to pH = 7 with HCl (~1 M) 
and analyzed by UPLC-MS.  HRMS (ESI) m/z:  [M+H]+ calcd. for C20H33N3O7S 




























Potassium (2S,3R,5R)-2-(2-acetamidoethylthiol)-carbapenam-3-carboxylate (44) and 
potassium (2R,3R,5R)-2-(2-acetamidoethylthiol)-carbapenam-3-carboxylate (45). 
The C2-SNAC carbapenams were generated from 38 as previously described and 
characterized (3). The diastereomers 44 and 45 were separated from each other and 
purified using an Agilent model 1100 HPLC equipped with a multi-wavelength 
ultraviolet–visible detector (210 nm) in conjunction with a reverse-phase Phenomenex 
Luna 10µ C18(2) 100 Å preparatory column (250 x 21.20 mm ID).  The mobile phase 
was 18% methanol and 82% buffer (10 mM potassium phosphate, pH 6.65) at a flow rate 
of 5 ml per min.  Compound 44 eluted at 23 min and compound 45 eluted at 18 min. 






Potassium (2S,3R,5R)-2-(4-phosphopantetheinyl)-carbapenam-3-carboxylate (46) 
and potassium (2R,3R,5R)-2-(4-phosphopantetheinyl)-carbapenam-3-carboxylate 
(47). The C2-phosphopantetheine carbapenams were generated from the C2-pantetheine 
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included: ~ 0.40 mg/mL enzyme, 15 mM substrate (~18 mg), 15 mM ATP, 20 mM KCl, 
10 mM MgCl2, and 50 mM Tris, pH 7.5 and were run for at least 2 hours at RT. The 
protein was removed by centrifugal filtration (Amicon, 10 kDa MWCO). The titled 
compounds were purified using the 1100 HPLC as described for 44 and 45 (detection: 
210 nm). The mobile phase was 15% methanol and 85% buffer (10 mM potassium 
phosphate, pH 6.65) for 47 and it eluted at approximately 17 min.  The mobile phase was 
20% methanol and 80% buffer for 46 and it eluted at approximately 17 min. Excess 
phosphate buffer was removed using Diaion® HP-20 resin. 46 and 47 have been 






Potassium (2S,3R,5R)-2-CoA-carbapenam-3-carboxylate (48) and potassium 
(2R,3R,5R)-2-CoA-carbapenam-3-carboxylate (49). The C2-CoA carbapenams were 
generated from the carbapenem 38 (31 mg, 0.11 mmol), which was dissolved in 
tetrahydrofuran (0.40 mL). Coenzyme A (49 mg, 0.064 mmol) was dissolved in water 
and added to 38 along with triethylamine (6.3 µL, 0.045 mmol). The solution was stirred 
for 75 min. The reaction mixture was then transferred to a pressure tube along with 10% 
Pd on carbon, 0.5 mL 0.5 M potassium phosphate (pH 7), 1 mL water, and 1 mL 
tetrahydrofuran and shaken on a Parr apparatus for 1 h under hydrogen (20 psi). The 
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(15 mL).  The aqueous layer was filtered through a 0.2 µm nylon filter and lyophilized. 
Prior to HPLC injection, the sample was dissolved in water and filtered through a 
centrifugal device (Amicon, 10 kDa MWCO). The diastereomers 48 and 49 were 
separated from each other and purified using an Agilent 1100 HPLC (detection: 254 nm). 
The mobile phase was 13% methanol and 87% buffer (10 mM potassium phosphate, pH 
6.65) at a flow rate of 5 ml per min.  Compound 48 eluted at 22 min and compound 49 
eluted at 17.5 min. Excess phosphate buffer was removed using Diaion® HP-20 resin. 
48: 1H-NMR (300 MHz. D2O) δ: 8.51 (s, 1H), 8.24 (s, 1H), 6.14 (d, J = 6.8 Hz, 1H), 
4.52-4.55 (m, 1H), 4.19 (dd, J = 4.5, 3.4 Hz, 2H), 4.10 (d, J = 5.4 Hz, 1H), 3.95 (s, 1H), 
3.90 (dd, J = 4.7. 2.2 Hz, 1H), 3.74 (ddd, J = 18.0, 11.5, 6.4 Hz, 2H), 3.50 (dd, J = 9.9, 
5.0 Hz, 1H), 3.42 (td, J = 6.5, 2.4 Hz, 2H), 3.36-3.40 (m, 2H), 3.27 (d, J = 5.1 Hz, 1H), 
2.84 (dd, J = 16.3, 2.0 Hz, 1H), 2.73 (q, J = 8.0 Hz, 2H), 2.53 (dt, J = 14.1, 6.6 Hz, 1H), 
2.42 (t, J = 6.8 Hz, 2H), 1.62 (dt, J = 14.0, 7.0 Hz, 1H), 0.82 (s, 3H), 0.69 (s, 3H); 
HRMS (ESI) m/z:  [M+H]+ calcd. for C28H43N8O19P3S 921.1656; found 921.1636; 49: 
1H-NMR (400 MHz. D2O) δ: 8.51 (s, 1H), 8.25 (s, 1H), 6.14 (d, J = 6.8 Hz, 1H), 4.53-
4.55 (m, 1H), 4.47 (d, J = 6.7 Hz, 1H), 4.19 (dd, J = 4.6, 3.4 Hz, 2H), 3.97-4.06 (m, 1H), 
3.95 (s, 1H), 3.88 (td, J = 6.5. 3.6 Hz, 1H), 3.73-3.78 (m, 2H), 3.24-3.49 (m, 6H), 2.75 
(dd, J = 16.6, 2.1 Hz, 1H), 2.70 (dd, J = 10.1, 6.8 Hz, 2H), 2.62-2.65 (m, 1H), 2.42 (t, J = 
6.5 Hz, 2H), 2.20-2.29 (m, 2H), 1.95-2.02 (m, 1H), 0.81 (s, 3H), 0.68 (s, 3H); HRMS 
(ESI) m/z:  [M+H]+ calcd. for C28H43N8O19P3S 921.1656; found 921.1628. 48 and 49 
have been characterized previously by Moshos (3) using an enzymatic synthesis of the 
CoA moiety.  
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Chapter 3 
 
Consecutive Radical SAM Methylations by ThnK Form the 




	   Apart from the identification of ThnE and ThnM in forming the (3S,5S)-
carbapenam 3 (1) and ThnR, ThnH, and ThnT in the stepwise truncation of coenzyme A 
(CoA) (2), the timing of the carbapenam(em) tailoring events including introduction of 
the C2-substituent, alkylation at C6, ring inversion, and desaturation remain shrouded in 
mystery. Unique to the complex carbapenem gene clusters are three apparent cobalamin-
dependent radical S-adenosylmethionine (RS) enzymes ThnK, ThnL, and ThnP (all 
annotated as Class B RS methylases) (3), which we now demonstrate likely play critical 
roles in the central undefined steps of thienamycin biosynthesis. The challenge of 
deciphering their activities is exacerbated by their intrinsic instability, unknown 
substrates, and multiple possible enzymatic reactions. We have taken the first step in 
illuminating the obscure center of the thienamycin biosynthetic pathway by identifying 
substrates for ThnK and establishing that this enzyme performs two consecutive 
methylations to generate the C6-ethyl side chain stereospecifically. While other RS 
cobalamin-dependent enzymes that act on carbon have been investigated (4-7), this is the 
first in vitro characterization of a RS methylase acting sequentially to form a side chain.   
 
Results and Discussion 
A library of candidate substrates and product standards was prepared (Chapter 2), 
including the simple (3S,5S)-carbapenam 3 and related C2 and C6-substituted derivatives 
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8-12. The library was biased toward structures with the (3S,5S)-stereochemistry, 
matching that of the ThnM product 3, and those bearing the 6R-configuration (8, 9) 
matching that of thienamycin (Figure 3.1A). A pantetheinyl moiety was selected for the 
side chain at C2 (10-12) in keeping with the OA-6129 series of metabolites that has been 
isolated from carbapenem producers (8).  
Work began with the best behaved of these three RS enzymes. ThnK was cloned 
from Streptomyces cattleya, where experimental conditions were found that gave 
Figure 3.1: Carbapenam synthetic library and detection and quantification of SAM 
products of ThnK.  
(A) Compounds synthesized to probe ThnK activity. (B) LC-MS/MS detection of 
enzymatic SAM co-products, SAH (385.4 →  136 m/z) and 5’-dA (252.1 →  136 m/z).  
The extracted-ion chromatograms (EICs) for the transitions of SAH and 5’-dA are shown 
for each reaction.  The reaction with compound 11 gave the highest levels of these SAM 
co-products. Quantified levels of SAH and 5’dA are shown for each reaction. 
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63	  
moderate levels of soluble protein when expressed with a C-terminal His6-tag in E. coli 
Rosetta 2(DE3). ThnK was expected to utilize both an iron-sulfur (Fe/S) cluster and 
cobalamin, so protein production was conducted in ethanolamine-M9 medium, which 
facilitates uptake of externally supplied hydroxocobalamin into E. coli, and with 
concurrent expression of the Azotobacter vinelandii isc operon, encoded on plasmid 
pDB1282. ThnK was purified under strictly anaerobic conditions.  Its UV-visible 
spectrum revealed a 420 nm shoulder (Figure 3.2) typical of a bound iron-sulfur cluster.  
The relative stoichiometry of iron and sulfide bound by the as-isolated protein was 
determined to be 7.4 ± 1.4 and 3.7 ± 0.8 per polypeptide, respectively, consistent with the 
presence of a [4Fe-4S] cluster.  Apparent excess iron has been observed with other RS 
enzymes (6, 9), and was similarly seen in an alanine variant control below. 



















Figure 3.2: UV-Visible spectrum and SDS-PAGE of ThnK.  
The UV-visible spectrum of ThnK shows a 420 nm shoulder, 
indicative of a bound iron sulfur cluster. 
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To determine whether any of our library compounds was a substrate for ThnK, a 
LC-MS analytical screen was developed whereby enzymatic reactions were monitored 
for appearance of the expected RS methylase co-products, S-adenosylhomocysteine 
(SAH) and 5'-deoxyadenosine (5’-dA) (10, 11). Initial screens were conducted with 
ThnK, SAM, and potential substrates in the presence of methyl viologen and NADPH as 
the Fe/S cluster reductants (5). The (3S,5S)-carbapenam and related C6-methyl and ethyl 
derivatives (3, 8, and 9) gave nearly background (no-substrate control) levels of SAH and 
5’-dA (Figure 3.3).  
In contrast, however, these SAM co-products accumulated when ThnK was 
incubated with C2-substituted carbapenams, suggesting that the full methyl transfer 
reaction(s) had occurred with these substrates (Figure 3.1B). Alternate Fe/S cluster 
















Figure 3.3: Detection of SAM-derived products of ThnK with compounds 3, 8, and 9.  
LC-MS/MS was used to detect SAM-derived coproducts, SAH (385.4 → 136 m/z) and 5’-
dA (252.1 → 136 m/z).  The extracted-ion chromatograms (EICs) for the transitions of 
SAH and 5’-dA are overlaid for each reaction.  The reactions with compounds 3, 8, and 9 
show about the same level of turnover as the reaction without substrate.  Reactions were 
run for approximately 2 hours at room temperature. 
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reductants, including dithionite and the flavodoxin/flavodoxin reductase/NADPH 
reducing system were also examined, but did not give improved activity (Figure 3.4).   
To assess enzymatic turnover, the amounts of SAH and 5’-dA were quantified by 
LC-MS/MS (Figure 3.1B). Compounds bearing the now (3R,5R)-stereochemistry with a 


























Figure 3.4: LC-MS/MS comparison of enzymatic turnover using different iron-
sulfur cluster reductants.   
The extracted-ion chromatograms (EICs) for the transitions of SAH (385.4 →  136 
m/z) and 5’-dA (252.1 → 136 m/z) are overlaid for each reaction.  Methyl viologen 
with NADPH gave higher turnover than dithionite or flavodoxin with flavodoxin 
reductase and NADPH.  Reactions were run for approximately 2 hours at room 
temperature with substrate 11. 
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pantetheine side chain at C2 gave the greatest levels of turnover. Therefore, each C2 
diastereomer (compound 10 or 11) was tested individually. The (2R,3R,5R)-carbapenam 
11 yielded ~2-fold higher amounts of SAM co-products. These stereochemical 
preferences were found to be reproducible (12) and SAH and 5’dA were present in 
approximately equimolar amounts in each reaction. 
To test the role of the [4Fe-4S] cluster in catalysis, a variant of ThnK was 
generated where the conserved cluster binding motif Cx3Cx2C was changed from three 
cysteine to three alanine residues. The variant protein was prepared as described above 
for wild-type ThnK and incubated with substrate 11. The inactivated enzyme did produce 
low levels of SAH, but no detectable 5’-dA (Figure 3.5) consistent with reliance of the 
wild-type enzyme on a functional Fe/S cluster.  
















Figure 3.5: Fe/S cluster required for ThnK activity. 
 
LC-MS/MS was used to detect SAM-derived coproducts, SAH (385.4 → 136 m/z) and 
5’-dA (252.1 → 136 m/z).  The extracted-ion chromatograms (EICs) for the transitions 
of SAH and 5’-dA are overlaid for each reaction.  Alteration of the Cx3Cx2C motif to 
Ax3Ax2A resulted in little SAH production and no 5’-dA production.  Reactions were 
run for approximately 2 hours at room temperature with substrate 11. 
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ThnK was also expressed in M9 medium lacking hydroxocobalamin. The purified 
protein with substrate 11 did not produce SAH or 5’dA; however, enzymatic activity 
could be rescued if cobalamin was added to the reaction mixture (Figure 3.6). 
The amount of cobalamin that co-purifies with ThnK was quantified for further 
evidence that cobalamin is a true enzymatic cofactor. A sample of ThnK was purified by 
Fast Protein Liquid Chromatography (FPLC) and verified to be active. The protein was 
then reacted with potassium cyanide to generate dicyanocobalamin. The level of 
cobalamin incorporation was estimated to be 40% by UV/Visible spectroscopy 
(absorption at 367 nm for dicyanocobalamin).















Figure 3.6: Cobalamin required for ThnK activity.   
LC-MS/MS was used to detect SAM-derived coproducts, SAH (385.4 →  136 m/z) and 
5’-dA (252.1 → 136 m/z).  The extracted-ion chromatograms (EICs) for the transitions 
of SAH and 5’-dA are overlaid for each reaction.  ThnK, expressed in and isolated from 
E. coli cultured in the absence of cobalamin, was either given no cobalamin, HOCbl, or 
MeCbl.  Added cobalamin was able to rescue ThnK activity with MeCbl yielding 
higher levels of SAH and 5’-dA than HOCbl.  Reactions were run for 1 hour and 10 
minutes at room temperature with substrate 11. 
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We next sought to determine how the substrate was transformed during the 
reaction with ThnK. Assays with 11 were analyzed by UPLC-HRMS.  Exact masses were 




























































































































Figure 3.7: ThnK product detection and additional synthetic compounds.   
(A)  UPLC-HRMS detection of carbapenams from ThnK reaction with compound 11.  
The bottom, middle, and top traces show the extracted-ion chromatograms (EICs, m/z ± 
0.05) for unreacted substrate (432.18 m/z), methylated product (446.20 m/z), and 
ethylated product (460.21 m/z), respectively. (B) UPLC-HRMS detection of carbapenams 
from ThnK reaction with compound 41b as compared to synthetic standard 43.  The 
bottom, middle, and top traces show the extracted-ion chromatograms (EICs, m/z ± 0.05) 
for unreacted substrate 41b (446.20 m/z), ethylated product (460.21 m/z), and C6-ethyl 
synthetic standard (460.21 m/z), respectively.  The ethylated product of 11 (A) and the 
ethlyated product of 41b match the synthetic standard 43 (B). (C) Additional compounds 
synthesized to analyze ThnK reaction.  Note: Compound 42 is a racemate and 
diastereomeric at C2; Compounds 41a and 41b are diastereomeric at C2, but enriched for 
the diastereomer shown (approx. 3:1 and 3:2, respectively); Compound 43 is 
diastereomeric at C2. (D) Summary of ThnK activity. 
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methylated (calc: m/z 460.2117, found: 460.2104) modifications of the substrate. The 
extracted-ion chromatograms for these masses showed retention times that were 
consistent with increasing hydrophobicity relative to the substrate (Figure 3.7A). The 
highly diagnostic β-lactam mass fragment (calc: m/z 390.1699) corresponding to the loss 
of a ketene from cleavage of the β-lactam ring (13) was observed (found: m/z 390.1701) 
(Figure 3.8), which was further consistent with methylation at C6.  
To establish SAM as the methyl donor, additional ThnK reactions were performed 
with S-adenosyl-L-[methyl-d3]methionine (d3-SAM). The corresponding M+3 m/z shift 
(Figure 3.8 and Figure 3.9) was observed for the methylated product and an M+5 m/z 
shift was seen for the twice-methylated product (Figure 3.9), fully in accord with 



























Subst. Prod. R = m/z  m/z 
11 -CH3 446.1954  390.1701 
41b -CH2CH3 460.2111  390.1681 
11 -CD3 449.2142  390.1700 
41b -CH2CD3 463.2299  390.1695 
 
Figure 3.8: Detection of β-lactam parent and fragment ions.  
UPLC-HRMS was used to detect carbapenam parent and fragment ions from ThnK 
reactions with 11 or 41b.  Characteristic MS fragmentation of β-lactam-containing 
compounds results in loss of a substituted (R) ketene as depicted.  Using d3-SAM or 
natural abundance SAM in the enzymatic reaction affects the observed m/z of the parent 
ion, but not the observed m/z of the fragmentation ion consistent with methylation 
occurring at C6. 
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To secure the stereochemistry of the first methylation, synthesis of a set of C6-
methylcarbapenams (41a, 41b, 42, Figure 3.7) was carried out and assayed with ThnK. 
While compounds 41a and 42 displayed trace or no measurable activity, respectively, 
41b afforded unequivocal production of SAH and 5’-dA (Figure 3.10). This result 
underscored the importance of the stereochemical relationship between the C3-
carboxylate and the pantetheinyl side chain and confirmed that the C6-methyl is attached 
in the R-configuration, as occurs in thienamycin. By UPLC-ESI/MS analysis, the 




























Figure 3.9: Product detection of ThnK assays with d3-SAM. 
(A) UPLC-HRMS detection of carbapenams from ThnK reaction with compound 11 and 
d3-SAM.  The bottom, middle, and top traces show the extracted-ion chromatograms 
(EICs, m/z ± 0.05) for unreacted substrate (432.18 m/z), methylated product (449.22 
m/z), and ethylated product (465.24 m/z), respectively.  The middle and top traces show a 
+3 m/z and a +5 m/z shift, respectively, from Figure 3.7A.  (B) UPLC-HRMS detection 
of carbapenams from ThnK reaction with compound 11 and natural abundance SAM.  
The shifted masses observed in A are not present in B. 
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and retention time of the ethylated product of compound 11 (Figure 3.7A and B). In 
further support, the (6R)-ethyl standard 43 was synthesized and determined to match the 
aforementioned products by retention time, exact mass, and fragmentation pattern, as 
expected (Figure 3.7A and B). The observed activity of ThnK is summarized in Figure 
3.7D. 
Mechanistically, ThnK resembles GenK, a cobalamin-dependent RS C-methylase 
in gentamicin biosynthesis (5), as both produce near equimolar amounts of SAH and 5’-
dA during catalysis. Early labeling experiments established that the C6-ethyl side chain 
of thienamycin was derived from methionine (14). A labeled carbon was also found in 
the C6-hydroxymethyl side chain of northienamycin, a minor co-metabolite of 
thienamycin, suggesting a singly-methylated intermediate in the formation of the ethyl 















Figure 3.10: Detection of SAM-derived products of ThnK with compound 41b.   
LC-MS/MS was used to detect SAM-derived coproducts, SAH (385.4 →  136 m/z) and 
5’-dA (252.1→136 m/z).  The extracted-ion chromatograms (EICs) for the transitions 
of SAH and 5’-dA are overlaid for each reaction.  The reaction with compound 41b 
shows increased turnover compared to the no substrate control.  Reactions were run for 
2 hours and ten minutes at room temperature. 
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side chain (14). The present in vitro analysis of ThnK agrees with these early 
experiments. An experiment incorporating chiral [1H, 2H, 3H-methyl]-L-methionine 
demonstrated that the absolute configuration of the terminal methyl in the C6-side chain 
was largely retained, consistent with an overall methyl transfer process involving two 
inversions and a methyl-cobalamin intermediate (15). The B12-dependence of ThnK 
reactions established above supports the role of a methylcobalamin intermediate, as has 
been implicated in other methyltransferases including TsrM (4, 5) and GenK (5). While 
the tryptophan methylase TsrM may utilize a similar intermediate, the enzyme is likely 
mechanistically distinct from ThnK and GenK because it does not produce detectable 
levels of 5’-dA (4, 5). 
 The catalysis of consecutive methylations observed for ThnK likely occurs 
elsewhere in nature. Within the carbapenem family, the carpetimycins have three carbons 
in their C6 side chain (16) suggesting that a ThnK ortholog may be responsible for three 
methyl transfers. The natural product pactamycin has traditionally been compared to 
thienamycin because both possess a hydroxyethyl side chain (14). A recent genetic 
knockout study suggests, however, that more than one enzyme takes part in attaching the 
ethyl group (17). While sequential methylations appear not to occur by a single enzyme 
in pactamycin biosynthesis, other RS enzymes including Swb9 (18) and PoyB or PoyC 
(19) in quinomycin and polytheonamide biosynthesis, respectively, have been implicated 
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Conclusions 
 These seemingly related biochemical examples notwithstanding, the data reported 
here establish notable catalytic roles for ThnK. It methylates in two distinct chemical 
environments (alpha to the β-lactam ring and on a methyl group). The second methyl 
transfer presumably involves a primary radical intermediate, a particularly high-energy 
species. By identifying favorable substrates for ThnK and elucidating its activity, we 
have gained additional clues about the unknown central steps in thienamycin biosynthesis 
as well. With formation of the ethyl side chain accounted for, ThnL and ThnP can 
provisionally be assigned non-methyltransferase functions, potentially distinct chemistry 
for the RS-cobalamin family, as both proteins are essential for carbapenem production 
(20, 21). Since ThnK activity was only observed when a C2-side chain was present 
(compounds 10-12 vs. 3, 8, and 9), we deduce that C2-thioether formation likely 
mediated by ThnL or ThnP precedes C6-methylation in the pathway. The stereochemical 
preference for (2R)-pantetheinyl carbapenams 11 and 41b indicates that the thiol is 
possibly introduced in the 2-exo-configuration. Furthermore, the observation of activity 
with substrates matching the (3S,5S)-carbapenam 3 at C5 (compounds 10, 11, and 41b) 
suggests that bridgehead epimerization occurs after C6-methylation (ethylation). 
Consequently, C2-thiol attachment, C6-alkylation, and C5-epimerization likely occur in 
that order. The orchestration of these biosynthetic events with C2/3-desaturation and 
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Materials and Methods 
 
General methods and abbreviations: 
 
hydroxocobalamin (HOCbl) 
4-(2-hydroxyethyl)-1-piperazineethane- sulfonic acid (HEPES) 
isopropyl β-D-1-thiogalactopyranoside (IPTG) 
2-mercaptoethanol (BME) 
methylcobalamin (MeCbl) 
methyl viologen (MV) 
nicotinamide adenine dinucleotide phosphate hydrate (NADPH) 
phenylmethysulfonyl fluoride (PMSF) 
other reagents were purchased from commercial sources unless otherwise noted  
 
Restriction enzymes, DNA modifying enzymes, and PCR reagents were obtained from 
New England Biolabs (Ipswich, MA). Plasmid kits were from Thermo Scientific 
(Waltham, MA).  E. coli DH5α (Invitrogen) was usually used for DNA cloning and ThnK 
expression was done in E. coli Rosetta 2(DE3) (Novagen).  The plasmid pDB1282 was 
utilized for Fe/S cluster expression (22).  SAM and S-adenosyl-L-[methyl-d3]methionine 
(d3-SAM) were synthesized as described previously (23).  Recombinant flavodoxin (Flv) 
and flavodoxin reductase (Flx) were over-produced in E. coli as previously described 
(24).  Plasmid DNA was sequenced by the Synthesis and Sequencing Facility of the 
Johns Hopkins University.   
 
 
Cloning and Expression of Streptomyces cattleya ThnK.  
 The thnK gene was PCR amplified from genomic DNA of Streptomyces cattleya 
(NRRL8057) using the following primers:  
5’– CAAGACATATGACCGTCCCCGCCGCGC – 3’,  
5’–TATCTCGAGCCGCTGCTCGGTCAGGACGGG – 3’.  The thnK PCR product was 
digested using NdeI and XhoI and ligated into the vector pET29b (Novagen) to obtain the 
C-terminal 6-His construct of thnK.  The plasmid was sequence-verified. The 
pET29b:thnK was transformed into E. coli Rosetta DE3 for expression of ThnK as a C-
terminal His6 construct.  The thnK Rosetta strain was also transformed with the vector 
pDB1282, containing the ISC operon with arabinose induction (22).   The resulting strain 
was grown in 4 x 3.5 L of Ethanolamine-M9 medium (25), which included 
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hydroxocobalamin (HOCbl), and was supplemented with FeCl3 (~0.14 mM) at 37 °C and 
shaken at 180 rpm.  When the optical density of the cultures reached 0.3 at 600 nm, 25 
µM FeCl3, 150 µM cysteine, and 0.1% arabinose were added.  The cultures were chilled 
on ice (~45 min) and an additional 25 µM FeCl3, 150 µM cysteine, and 0.1% arabinose 
were added at optical density 0.4-0.6 (8-10 h).  ThnK expression was induced with 1 mM 
IPTG and the cultures were shaken at 180 rpm overnight at 19 °C.  Cells were collected 
by centrifugation (4,000 × g, 12 min), which were then frozen on liquid nitrogen and 
stored for later use. 
 
Anaerobic Purification of ThnK.  
 Enzyme purification was performed in an anaerobic chamber (Coy).  Frozen cells 
were resuspended in lysis buffer (10% glycerol, 300 mM KCl, 50 mM HEPES pH 8.0, 10 
mM BME, 2-5 mM imidazole) along with lysozyme (1 mg/mL final volume), PMSF (1 
mM), DNAse (~ 0.1 mg/mL final volume), and optional HOCbl (~0.4 mg/g cell paste).  
Cells were lysed by sonication and insoluble material was removed by centrifugation 
(50,000 × g for 1 h at 4 °C).  Soluble ThnK was allowed to bind to pre-equilibrated 
TALON CoII resin (Clontech) and purified by immobilized metal affinity 
chromatography.  The resin was washed with 5 mM and 10 mM imidazole in lysis buffer. 
The protein was eluted using 250 mM imidazole in the lysis buffer.   The enzyme was 
concentrated using Amicon centrifugal filter devices (Millipore) with a 10 kDA 
molecular weight limit.  Using a PD-10 column (GE Biosciences), the protein was 
transferred into assay buffer (10% glycerol, 300 mM KCl, 50 mM HEPES pH 7.5, 10 
mM BME). 
 
	   76	  
 
ThnK Protein Analysis.  
 The concentration of ThnK was determined by the Bradford assay (26) (Varian 
Cary 50 Bio UV/ Visible Spectrophotometer) using Coomassie Protein Assay Reagent 
(Thermo Scientific).  A concentration correction factor was obtained using amino acid 
analysis (Molecular Structure Facility, UC Davis).  The amount of iron bound by ThnK 
was determined by established methods (27, 28), and the amount of sulfide was 
determined as reported (29).  
 
ThnK Activity Assays.  
 ThnK was mixed with 50-100 mM HEPES pH 7.5, 200 mM KCl, 1 mM SAM or 
d3-SAM, 1 mM methyl viologen, 4 mM NADPH, and 1 mM substrate.  Initial activity 
screens also included 0.5 mM HOCbl and 0.5 mM MeCbl, though it was later determined 
to be unnecessary for activity.  Assays of potential substrates lacking a C2-substituent 
also included 1 mM cysteine and 1 mM coenzyme A.  When utilized, dithionite (3 mM) 
or flavodoxin (90 µM), flavodoxin reductase (9 µM), and NADPH (1 mM) were 
supplemented at the indicated concentrations in place of methyl viologen and NADPH 
(default reductant unless otherwise noted).  Assays were conducted anaerobically at room 
temperature and were typically run for 1-2 h. 
 
ThnK SAH and 5’-dA Quantification Assays.  
 ThnK (50 µM, final concentration) was mixed with 100 mM HEPES pH 7.5, 200 
mM KCl, 1 mM SAM or d3-SAM, 1 mM methyl viologen, 4 mM NADPH, and 1 mM 
substrate.  Assays were run anaerobically for 2 h and 10 min at room temperature.   
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No-cobalamin ThnK Expression, Purification, and Activity.  
 The ThnK wild type Rosetta strain was grown in standard M9 medium lacking 
cobalamin, but supplemented with FeCl3 (~0.14 mM) and thiamine (0.074 mM).  
Expression and purification of the no-cobalamin ThnK was conducted as described for 
the wild type protein, but no HOCbl was added during purification.  Assays were 
conducted with 50 µM ThnK and 1 mM HOCbl or 1mM MeCbl when utilized and were 
otherwise as described for ThnK from ethanolamine medium. 
 
ThnK Cobalamin Quantification.  
 FPLC-purified ThnK (41 µM by Bradford) was diluted (11.2 µM, 1 mL total 
reaction volume) and reacted with potassium cyanide (100 mM final). The solution was 
boiled for 5 min then centrifuged (5 min, max speed). The absorption was measured at 
367 nm (dicyanocobalamin, extinction coefficient 30,800 M-1cm-1), giving an estimate of 
4.7 µM cobalamin or approximately 40% incorporation. 
 
Knockout of Cx3Cx2C Motif in ThnK and Mutant Protein Expression, Purification, 
and Activity.  
 The pET29b:thnK plasmid was used as a template for a two-step PCR method that 
utilized the following primers:  5’-CGC GGC GCC CCC TAC TCG GCT GCC TTC 
GCC GAC TGG-3’ and 5’-CCA GTC GGC GAA GGC AGC CGA GTA GGG GGC 
GCC GCG-3’.  The C206A-C210A-C213A PCR product was digested with NdeI and 
XhoI and ligated into the pET29b vector.  The resulting plasmid was sequenced and 
found to be without error.  The mutant thnK vector was transformed into an E. coli 
Rosetta DE3 strain containing the pDB1282 plasmid.  Expression, purification, and 
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assays of the mutant ThnK (85 µM final concentration) were conducted as described for 
the wild type protein.  
 
LC-MS Analysis of Carbapenams.   
 UPLC-MS detection of carbapenams was conducted on a Waters Acquity H-Class 
UPLC system equipped with a Waters Acquity BEH UPLC column packed with an 
ethylene bridged hybrid C18 stationary phase (2.1 mm x 50 mm, 1.7 um) followed by a 
multi-wavelength UV-Vis diode array detector coupled with accurate mass analysis by a 
Waters Xevo-G2 Q-ToF ESI mass spectrometer.  Mobile phase: 0-1 min 100% water + 
0.1% formic acid, 1-7.5 min up to 80% acetonitrile + 0.1% formic acid, 7.5 – 8.5 min 
isocratic 80% acetonitrile + 0.1% formic acid, 8.5-10 min 100% water + formic acid.  
The flow rate was 0.3 mL/min.  The first min of eluant was discarded prior to MS 
analysis. 
 
LC-MS Analysis of SAH and 5’-dA.  
 LC-MS detection of S-adenosyl-homocysteine (SAH) and 5'-deoxyadenosine (5’-
dA) was carried out on an Agilent Technologies (Santa Clara, CA) 1200 system equipped 
with an autosampler and an Agilent Technologies Zorbax Rapid Resolution Extended-
C18 column (4.6 mm × 50 mm, 1.8 µm particle size) and coupled to an Agilent 
Technologies 6410 QQQ mass spectrometer.  Assay mixtures were quenched with H2SO4 
and insoluble material was pelleted prior to analysis.  Method 1 (Compounds 3, 8, 9): 
method is similar to that reported previously (30). Mobile phase:  The initial conditions 
included 95% solvent A (40 mM aqueous ammonium acetate, pH 6.0 with glacial acetic 
acid, and 5% methanol) and 5% solvent B (methanol), 0.5-5 min up to 13% B, 5-6.5 min 
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up to 27% B, 6.5-7.0 min up to 53% B, 7.0-7.5 min isocratic 53% B, 7.5-8 min down to 
5% B, 8.0-10.0 min re-equilibrate at 5% B. Method 2 (Compounds 10-12, 41-43): Mobile 
phase:  The initial conditions included 90.5% solvent A (0.1% formic acid, pH 2.6) and 
9.5% solvent B (methanol), 0-0.2 min 9.5% B, 0.2-3.3 min up to 9.8% B, 3.3-4.1 min up 
to 30% B, 4.1-4.7 min up to 60% B, 4.7-5.1 min isocratic 60% B, 5.1-5.5 min down to 
9.5% B, 5.5-8.7 min isocratic 9.5% B.  Data collection and analysis were conducted with 
the associated MassHunter software package.  Detection of SAH and 5’-dA was 
performed using electrospray ionization in the positive mode (ESI+) with multiple 
reaction monitoring (MRM).  The masses used for the detection of SAH and 5’-dA are 
shown in Table 3.1.  Quantification of SAH and 5’d-A levels was conducted using the 
MassHunter software with appropriate standard curves and utilized a tyrosine internal 




Table	  3.1:	  	  LC-­‐MS	  mass	  fragments	  for	  detection	  of	  SAH	  and	  5’d-­‐A	  
	   Parent	  Ion	   Product	  Ion	  1	   Product	  Ion	  2	  
SAH	   385.4	   136	   134	  
5’-­‐dA	   252.1	   136	   119	  
Tyrosine	   182.0	   165	   123	  
	  
Table 3.1.  Detection of SAH and 5’-dA was performed using electrospray ionization in 
the positive mode (ESI+) with multiple reaction monitoring (MRM).  The masses used 
for the detection of SAH and 5’-dA are shown.  The mass transition from the parent ion 
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FPLC Purification of ThnK. 
	   Fast protein liquid chromatography (FPLC) was conducted on a HiPrep 16/60 S-
200 column using an ÅKTA liquid chromatography system (GE Biosciences) in a Coy 
anaerobic chamber (Grass Lake, MI) using assay buffer as described above. 
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 Chapter 4 
 
Attachment of Large, CoA-Derived Thiol Provides Side Chain in 




 The carbapenems are therapeutics of last resort within the β-lactam family of 
antibiotics due to their relative insusceptibility to common bacterial resistance 
mechanisms (1). Despite their medical importance, the carbapenems are produced 
commercially by total synthesis rather than by lower-cost fermentation methods, unlike 
other clinically-used members of the class (1). Increased understanding of the biological 
assembly of natural carbapenems, such as the paradigmatic thienamycin 7, would pave 
the way for semi-synthetic routes of production.  
 The early biosynthesis of thienamycin in Streptomyces cattleya involves two 
enzymes, ThnE and ThnM, which make the bicyclic (3S,5S)-carbapenam 3 (2) from 
simple metabolic building blocks. These two steps are paralleled in Pectobacterium 
carotovorum during the formation of the “simple” carbapenem 4 (3) where one additional 
enzyme, CarC, is able to complete the pathway by converting 3 to the antibiotic 4 (3). 
“Complex” carbapenems, including thienamycin and at least 50 structural variants from 
actinomyces, do not have a CarC homolog in their gene clusters (4), suggesting evolution 
of an alternate route to antibiotic formation. After 3 is biosynthesized in S. cattleya, 
however, only fragmentary information about the subsequent steps is known. Recent 
results, however, have demonstrated that the C6-ethyl side chain is formed by 
consecutive radical S-adenosylmethionine (RS) catalyzed methylations by ThnK (5). 
These experiments also suggested that the C2-thioether side chain was installed prior to 
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C6-alkylation. ThnK methyl transfer activity was exhibited with substrates bearing the 
C2-pantetheinyl moiety. It remains uncertain if this side chain represents a true 
biosynthetic intermediate. For more than two decades, cysteine was thought to be the 
source of the thioether, since labeled cystine was shown to be efficiently incorporated 
into thienamycin (6). However, isolated carbapenems bearing a C2-pantetheine (7) 
indicate that a larger thiol is attached. More recent experiments associate the sequential 
truncation of coenzyme A (CoA) with the creation of the cysteamine side of thienamycin 
(8), yet the identity of the thiol and the enzyme that attaches it to the carbapenam nucleus 
are unknown.  
 In addition to ThnK, there are two other RS enzymes encoded by the gene cluster 
(9), ThnL and ThnP, which are also classified as cobalamin-dependent RS methylases 
(10). It is likely that these two RS enzymes in fact have non-methylase functions, where 
one is possibly responsible for mediating the C2-thioether formation, as the two 
methylations have now been attributed to ThnK. Unfortunately, technical barriers of low 
enzyme solubility and stability coupled with unknown substrates have thus far impeded 
efforts to elucidate the functions of these two enzymes. In this work, we describe the 
synthesis of various C2-substituted carbapenams, including compounds that contain a full 
CoA moiety at C2, as well as an assessment of the in vitro activity of ThnK with these 
molecules. The high levels of turnover observed with the CoA-functionalized 
carbapenams strongly suggest that CoA or a closely related thiol is attached to the bicycle 
in the course of complex carbapenem biosynthesis. In a separate experimental approach, 
a heterologous expression system combined with a CarC competition assay now places 
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ThnL likely directly after ThnE/ThnM, implicating this RS protein as the probable 
candidate for the attachment of the C2-thiol. 
Results and Discussion 
To probe the identity of the thiol that is attached to the bicyclic carbapenam 
nucleus, we chose to evaluate the tolerance of ThnK towards variation in C2 side chain 
length. Previously, a pantetheinyl group on a carbapenam was shown to be sufficient to 
observe activity from ThnK (5), but other CoA-derived thioethers are biologically 
relevant and possible as well.  Within the thienamycin cluster, ThnR, ThnH, and ThnT 
are able to successively cleave CoA to 4-phosphopantetheine, pantetheine, and 
cysteamine, respectively (8). Thus, additional carbapenams representing the other 
possible truncation states (Figure 4.1) were desired, but substituting the more chemically 
inert N-acetylcysteamine (SNAC) for cysteamine. We began by synthesizing the 










































































































Figure 4.1: Overview of the synthesis of C2-substituted carbapenams to test with 
ThnK. 
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intermediate, pantetheine or SNAC can be inserted in a β-addition, as has been shown (5, 
12).  Additionally, we found that CoA itself could also be added into the carbapenem 
directly. High-performance liquid chromatography (HPLC) enabled separation of the C2-
diastereomers giving compounds 10-11, 44-45, and 48-49 (Figure 4.1). We utilized PanK 
(CoaA) (13) to convert the pantetheinyl compounds 10 and 11 into their corresponding 
phosphopantetheinyl analogs 46-47. 
ThnK was expressed and anaerobically purified as previously described (5). As a 
RS enzyme, ThnK requires a [4Fe-4S] cluster to reductively cleave S-
adenosylmethionine (SAM) to form a 5’-deoxyadenosyl radical, which can initiate 















Figure 4.2: Sequential methylations by ThnK.  
UPLC-HRMS detection of carbapenams from the ThnK reaction with compound 47. 
The bottom, middle, and top traces show the extracted-ion chromatograms (EICs) (m/z 
± 0.05) for unreacted substrate (512.15 m/z), methylated product (526.16 m/z), and 
ethylated product (540.18 m/z), respectively. 
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provided in our expression system. The enzyme also uses SAM as the source of the 
methyl groups that are transferred to the substrate. To evaluate the synthetic substrates, 
each compound (1 mM) was incubated with ThnK, [4Fe-4S] cluster reductants (methyl 
viologen, 1 mM and NADPH, 2 mM), and SAM (1 mM). ThnK was confirmed to 
perform consecutive methylations at C6, as expected (Figure 4.2). 
For assessment of the relative turnover with the various substrates, the RS 
methylase SAM-derived coproducts S-adenosylhomocysteine (SAH) and 5′-
deoxyadenosine (5′-dA) (15) were monitored by LC-MS/MS. Several trends were 







































Figure 4.3: LC-MS/MS detection of enzymatic SAM-derived coproducts SAH 
(385.4 → 136 m/z) and 5′-dA (252.1 → 136 m/z).  
The extracted-ion chromatograms (EICs) for the transitions of 5′-dA (A) and SAH (B) 
are shown for each reaction.  
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apparent from sampling the levels of accumulated 5′-dA (Figure 4.3A). Three compounds 
consistently gave the lowest turnover including both C2-SNAC molecules (44 and 45) 
and the pantetheine-substituted 10. The (2R)-carbapenam 11 gave higher levels of 5’-dA 
than its diastereomer 10, as had been observed previously (5). With the (2R)-series (45, 
11, 47, 49), only modest gains were made by derivatizing the side chain to 
phosphopantetheine (47) or CoA (49). In contrast, with the (2S)-series (44, 10, 46, 48), 
the phosphopantetheine (46) and CoA (48) analogs gave much better activity than the 
pantetheine compound 10. The (2S)-CoA carbapenam 48 produced the greatest amounts 
of 5’-dA. Correspondingly, these trends with 5’-dA levels mirrored those of SAH 
accumulation (Figure 4.3B). 
 The activity of ThnK with large CoA-derived side chains begs the question of 
which enzyme is responsible for attaching the C2-appendage. Interestingly, the only 
difference between substrates for ThnK and the (3S,5S)-carbapenam 3 is the C2-
thioether. We hypothesize that ThnL is directly after ThnE and ThnM in the pathway, 
providing the missing link between these enzymes and ThnK. Prior work on the 
thienamycin cluster is consistent with this role for ThnL. In a secretor-convertor pair 
experiment between knockout strains, it was noted that ThnL acted before ThnP in the 
pathway (16). Additionally, it has been reported that the ThnL knockout strain in S. 
cattleya accumulated a compound with a mass matching 3 (16). 
 To indirectly probe the possible biosynthetic activity of ThnL, we turned to 
Streptomyces as a heterologous host since carbapenem biosynthetic pathways occur in 
actinomyces and the RS protein has very limited solubility in E. coli. Specifically, S. 
lividans TK24 (17) and the genome-minimized S. coelicolor M1154 (18) strains were 
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selected. The early biosynthetic genes thnE and thnM were placed in succession under the 
ermEp promoter using the plasmid pUWL201PW (19). The ermEp-thnE-thnM construct 
was then moved to the integrative plasmid pMS82 (20), which contains a phage integrase 
for site-specific insertion into the Streptomyces genome. By placing the genes into the 
genome itself, they can be stably maintained, even in the absence of antibiotic selection. 
The pMS82/ermEp-EM plasmid was electroporated into E. coli ET12567 (pUZ8002), a 
methylation deficient strain, for conjugation to germinated spores from the two 
Streptomyces host strains. With the TK24-EM and M1154-EM strains in hand, a 
Southern blot was performed on digested gDNA isolated from each strain, which verified 
that both thnE and thnM were integrated into the hosts (Figure 4.4). 
Figure 4.4: Southern blot verifying insertion of thnE and thnM into S. lividans 
TK24-EM and S. coelicolor M1154-EM.
The first four lanes for each gene are S. lividans transformants and are followed by 
four lanes of S. coelicolor transformants and a negative and positive control. 
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To confirm that ThnE and ThnM were expressed and showed activity, an assay 
was developed to sensitively detect production of the (3S,5S)-carbapenam 3. We 
envisioned using the enzyme CarC to transform 3 into the carbapenem 4. As an active 
antibiotic, 4 can be facilely detected using a supersensitive E. coli (ESS) strain (21). The 
assay conditions were tested using synthetically-prepared 3 that was added to α-
ketoglutarate (8 mM), ferrous ammonium sulfate (80 µM), and ascorbic acid (2 mM) 
since CarC is an α-ketoglutarate-dependent, non-heme iron oxygenase (22). This mixture 
was combined with a cell-free extract (CFE) from E. coli cells expressing CarC, 
analogous to early work establishing the activity of the enzyme (22). The CarC CFE 
reaction produced a zone of inhibition on an ESS-seeded agar plate (Figure 4.5) as 
expected, confirming that the carbapenem 4 was produced. 
We initially examined the CFE from the Streptomyces strains containing ThnE/M, 
but did not observe production of 3 using the CarC assay. Reasoning that perhaps 3 was 
Figure 4.5: Production of the antibiotic 4 from the CarC assay with synthetic 
(3S,5S)-carbapenam 3. 
The CarC assay included α-ketoglutarate, ammonium iron(II) sulfate, ascorbic acid, 
and 1.4 mM substrate 3. The reaction was run at 28 °C for 1 h and 10 min before 
plating on ESS. 
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exported from the cell, we assayed the Streptomyces growth supernatant after removing 
the cells; zones of inhibition were evident. Importantly, the Streptomyces supernatant 
without the addition of CarC did not produce this effect. The zones of inhibition are 
specific for CarC activity since withholding ascorbic acid or α-ketoglutarate abolished the 
ability to kill ESS (Figure 4.6). The CarC assay confirmed ThnE and ThnM expression 
and activity in both TK24-EM and M1154-EM. 
In an effort to boost carbapenam production levels, we examined multiple growth 
media and supplements. For both the TK24-EM and M1154-EM strains, R5A+ medium 
(see Materials and Methods) was found to give the best production. Next, this growth 
medium was supplemented with the substrate for ThnE, L-pyrroline-5-carboxylic acid 1 
(P5C), or glutamate, the amino acid building-block for P5C. The P5C or glutamate 
Figure 4.6: Production of zones of inhibition are dependent on CarC activity. 
Withholding	  ascorbic acid (-C) or α-ketoglutarate	  (-­‐αKG)	  from	  the	  CarC	  assay	  
prevented	  formation	  of	  a	  zone	  of	  inhibition,	  which	  is	  present	  when	  all	  the	  
cofactors	  are	  available	  (R5A).	  Additional	  iron(II) was not necessary for the CarC 
assay as seen in the –Fe control, presumably because sufficient quantities are already 
present from the CarC expression. All reactions were conducted with R5A+ medium 
samples from the same M1154-EM culture.  	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additions, however, did not increase (3S,5S)-carbapenam 3 titers, suggesting that 
availability of these precursors was not limiting. Production of 3 was monitored for 5-6 
days and peak levels were typically observed between 3 and 4 days. 
Having integrated ThnE and ThnM into heterologous hosts, we generated EML 
strains by adding ThnL to the system. In parallel, we elected to make EMK strains for 
comparison. The C-terminal-His6 constructs of thnL and thnK were each placed under 
control of the ermEp promoter. Each gene was then moved to the pSET152 vector (23), 
which is similar to pMS82, but integrates at a different site in the Streptomyces genome. 
Transferring the pSET152 construct to E. coli ET12567 (pUZ8002) allowed for 
conjugation to the EM strains. Verification of protein expression for ThnL and ThnK was 
readily observed by SDS-PAGE for the TK24-EML and TK24-EMK strains (Figure 4.7), 
though was less evident in the corresponding strains in S. coelicolor. 
Figure 4.7: Detection of ThnL and ThnK in TK24-EML and EMK strains. 
Approximately 12 grams of cells from each strain were lysed and the proteins were 
concentrated by immobilized metal-affinity chromatography using TALON CoII resin. 
Samples were then analyzed by SDS-PAGE. 
EM  EML    EMK 
70 kDa 
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The CarC assay was again utilized to assess the effect of ThnL (Figure 4.8). If 
ThnL is unable to use the product of ThnE and ThnM, 3 will continue to diffuse into the 
medium. Upon reaction with CarC, the carbapenam will be converted to the active 
antibiotic, resulting in a zone on ESS. However, if ThnL is modifying 3, less is available 
to react with CarC, which should correspond to a smaller zone size.  
When the CarC “competition” assay was performed, the medium from TK24-
EML and M1154-EML strains typically gave comparable or slightly smaller zone sizes 
than the corresponding EM or EMK strains. Since ThnL is predicted to utilize cobalamin 
(10), we postulated that a possible deficiency of this cofactor could be limiting ThnL 
activity. The assay was repeated with two cultures for each strain (EM, EML, and EML 
in TK24 and M1154), one of which was supplemented with hydroxocobalamin (1 µM). 
While the zones corresponding to the EMK and EM strains showed no effect from the 
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added cobalamin, the zones from the EML strains were essentially non-existent (Figure 
4.9). The absence of a zone strongly suggests that ThnL functions directly after ThnE/M 
in the biosynthetic pathway. The requirement of cobalamin for maximal effect supports 
the use of the cofactor by ThnL. Thus far, attempted isolation of an intermediate from the 
EML strains has proven unsuccessful, but highlights the utility of the highly sensitive 
CarC competition assay to glean clues about thienamycin biosynthesis.  
Conclusions 
Thienamycin was first isolated over 35 years ago (24), yet difficult genetic 
manipulation in the producing strain and experimental limitations stemming from in vitro 
protein stability have thwarted elucidation of the biosynthetic pathway. In this work, we 
present an experimentally diverse approach to this problem including synthesis of 
Figure 4.9: CarC competition assay with TK24-EM, EML, and EMK strains. 
Strains with a (+) designation had 1 µM hydroxocobalamin supplemented in the growth 
medium.  The EML+ strain medium did not produce a zone, suggesting the (3S,5S)-
carbapenam was utilized by ThnL.   
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complex potential intermediates, anaerobic in vitro reactions, heterologous expression in 
Streptomyces, and a competition bioassay designed to shed light on the murky center of 
complex carbapenem assembly. In vitro reactions with ThnK showed that a small C2-
substituent (SNAC) was clearly not preferred. The low ThnK catalytic activity with 
compounds 44 and 45 suggests that a small thiol such as cysteine is not likely added 
directly to the bicyclic structure. Until now, a pantetheinyl group represents the largest 
carbapenam(em) C2 side chain that has been tested in vitro in potential substrates for 
biosynthetic enzymes (5, 8). After synthesizing and analyzing phosphopantetheine and 
CoA derivatives, we observed that these are better substrates for ThnK, indicating that 
larger side chains are preferred biosynthetically. While the (2S)-CoA carbapenam 48 
gave the highest levels of turnover, other extended side chain compounds (46, 47, 49) 
also gave good turnover, suggesting some promiscuity by the enzyme. This flexibility 
suggests a possible metabolic grid that allows for ThnR to remove the nucleotide-
monophosphate either before or after alkylation by ThnK. We note that with the C2-
thioethers, ThnK accepts both possible stereoisomers at C2. While phosphopantetheine 
cannot be definitively excluded, we propose that CoA itself is attached to the bicyclic 
carbapenam core prior to the methylations by ThnK.  
 Additionally, heterologous expression of ThnE/ThnM and ThnL combined with a 
CarC partition assay suggested that the (3S,5S)-carbapenam 3 is the substrate for ThnL. 
The lack of accumulation of 3 was observed in two separate EML-expressing species and 
was cobalamin-dependent, in further support of ThnL activity. Of further note, the CarC 
assay also implied that 3 is not an in vivo substrate for ThnK, as has been previously seen 
in vitro (5). As there is one chemical substitution separating the CoA-substituted 48 from 
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3, only one enzyme may function between ThnE/ThnM and ThnK. The in vivo 
expression experiments place ThnL as the missing step in the pathway and the probable 
enzyme for the linkage of the C2-CoA moiety. Examples of atomic sulfur inserting RS 
enzymes are known including both biotin synthase and lipoyl synthase, which use a 
second [Fe-S] cluster as a sulfur source (14). As a variation, the proteins MiaB and RimO 
catalyze methylthiolations and also contain a second [Fe-S] cluster, although the cluster 
is not cannibalized for sulfur. Instead, these proteins employ exogenous sulfide bound to 
the second cluster (25). Alternatively, the use of a sulfur-containing cofactor (CoA) and 
potentially cobalamin as well would be a novel adaptation in the RS enzyme family. 
Overall, the evidence for the role of ThnL in thienamycin biosynthesis presented here 
will guide future efforts to demonstrate directly the substrate of C2-attachment and 




Materials and Methods 
 
P5C Preparation. 
 P5C was synthesized using established methods (26). 
 
Synthesis of the ThnK substrates. 
 See Chapter 2 
 
Purification of ThnK. 
 See Chapter 3, including FPLC purification 
 
 
ThnK in vitro Reactions. 
 ThnK (2.9 µM) was mixed with 100 mM HEPES pH 7.5, 200 mM KCl, 1 mM 
SAM, 1 mM methyl viologen, 2 mM NADPH, and 1 mM substrate. Assays were 
conducted anaerobically at room temperature and were typically run for 2 h. LC-MS/MS 
detection of 5’-dA/SAH and LC-HRMS detection of carbapenams were conducted 
essentially as previously described (5). 
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Construction of the thnE/thnM Plasmid for Conjugation to Streptomyces.  
 The thnE gene was amplified by PCR from thnE in the pBluescriptII SK+ vector 
(27) using the following primers:  
5’-GGCATATGGGCGCGGCCGCCGGCGAGCGGAGAACC-3’ 
5’-GGCTCGAGGCTCCGCCCGATGACGCGGCGCATCCGCAC-3’ 
The PCR product was ligated into pBluescript and verified to be correct by automated 
sequencing. The thnE gene was excised using NdeI/XhoI and ligated to the same 
restriction sites in pET29b, creating pET29b/thnE. This plasmid was then digested with 
BlpI, blunt-ended with Klenow DNA polymerase, and then digested with NdeI. The 
vector pUWL201PW (19) was digested with HindIII, treated with Klenow, and digested 
with NdeI. Ligating the NdeI-blunt thnE into the digested pUWL201PW gave the vector 
pUWL201PW/thnE. 
thnM in pET29b (27) was digested with DraIII (thnM has a single BlpI site), 
treated with Klenow, and digested with NdeI. The NdeI-blunt thnM was ligated into the 
same digested pUWL201PW vector used for thnE, giving pUWL201PW/thnM. 
pUWL201PW/thnM was digested with XbaI, treated with Klenow, and digested 
with PstI.  This gave a RBS-thnM-C-His6 insert. pUWL201PW/thnE was digested with 
EcoRI, treated with Klenow, and digested with PstI.  The RBS-thnM-C-His6 construct 
was ligated into the digested pUWL201PW/thnE to give pUWL201/ermEp-EM (Figure 
4.10A), which was sequence-verified. The pUWL201/ermEp-EM was digested with PstI-
HF followed by treatment with Klenow. The purified DNA was partially digested with 
KpnI (there is a single KpnI site in thnM). The 3.5-kb ermEp-RBS-thnE-C-His6-RBS-
thnM-C-His6 fragment was ligated in pMS82 (20), which had been digested with 
HindIII/Klenow and KpnI. The pMS82/ermEp-EM plasmid (Figure 4.10B) was 
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electroporated into E. coli ET12567 (pUZ8002) cells and conjugated into spores of S. 
coelicolor M1154 and S. lividans TK24 for integration at the ϕBT1 site, creating the 
M1154-EM and TK24-EM strains. 
Construction of the thnK and thnL Plasmids for Conjugation to Streptomyces. 
 
The thnK gene in the pET29b vector was previously described (5). The thnL 




The thnL PCR product was digested using NdeI and XhoI and ligated into pET29b 
(Novagen) using the same restriction sites to obtain the C-terminal-His6 construct of 
thnL. The plasmid was sequence-verified. The C-term-His6 genes (thnK and thnL) were 
digested (BlpI for thnK; DraIII for thnL), blunted with Klenow, and digested with NdeI.  
These fragments were inserted into pUWL201PW at HindIII/Klenow-NdeI sites.  The 
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ermEp-C-term-His6 genes were digested (partial KpnI for thnK; KpnI for thnL), purified 
after gel electrophoresis if necessary (for partial digests), digested again (PstI for thnK; 
EcoRI for thnL), and then blunted with Klenow.  The inserts were ligated into the EcoRV 
site of pSET152 (23). The pSET152 plasmids for each gene were sequenced.  The 
plasmids were electroporated into the E. coli strain ET12567 (pUZ8002) for conjugation 
to the Streptomyces EM strains at the ϕC31 site.   
 
 
Conjugation to Streptomyces. 
  
 Spores were isolated from the desired Streptomyces strains (17, 18). The 
integrative plasmid (pSET152 or pMS82) containing the desired construct was 
electroporated into the E. coli strain ET12567 (pUZ8002).  The E. coli culture (50 mL, 
LB medium) was grown to OD600 = 0.4. The cells were pelleted by centrifugation (4000 
× g), washed twice (40 mL LB medium), and resuspended in 2 mL of LB medium. The 
Streptomyces spores (50 µL) were added to 0.5 mL of 2xYT media and kept at 50 °C for 
10 minutes. The spores were mixed with 0.5 mL of the E. coli donor strain resuspension. 
The mixture was centrifuged and the cell pellet resuspended in 300 µL of LB medium. A 
sample of the resuspension (100 µL) was plated on MS + MgCl2 agar medium. The cells 
were grown for 16-20 hours at 28 °C. Nalidixic acid, hygromycin B (pMS82), and 
apramycin (pSET152) were added to the top of the plates in sterile water and colonies 
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Southern Blot Hybridization. 
 
 The plasmid pUWL201/ermEp-EM was digested with KpnI, NdeI, and XhoI to 
create DNA probes. The DNA bands corresponding to thnE and thnM were isolated 
(there is a single KpnI site in thnM, resulting in the probe being slightly smaller than the 
full gene). The gDNA from S. lividans-EM and S. coelicolor-EM strains was isolated. 
The particular EM strains for the Southern blot also contained carC at the ϕC31 site, the 
same location where either thnL or thnK was eventually inserted. The gDNA was 
digested with NdeI and XhoI and run on an agarose gel (1%) along with appropriate 
positive and negative controls. The DNA was transferred to a nylon membrane using the 
Whatman Turboblotter Rapid Downward Transfer System. The membrane was wrapped 
in a nylon cloth and placed in a sealed glass tube with prehybridization buffer (5× SSC, 
5× Denhardt’s, 50% formamide, 1% SDS, 100 µg/mL denatured salmon sperm DNA). 
The tube was rotated for 3 hours at 68 °C.  The 32P-labeled probe was prepared by mixing 
5 µL New England Biolabs buffer 2, 25 µL primer mix, 2 µL dATP, 2 µL dTTP, 2 µL 
dGTP, 28 µL denatured probe DNA, 5 µL [α-P32]dCTP, and 1 µL Klenow DNA 
polymerase.  The reaction was run for 60 min at 37 °C.  The probes were purified and 
denatured (90 °C for ~10 min, then on ice) and added to the glass tube with the nylon 
membrane and left overnight rotating at 68 °C.  The membrane was washed using two 
buffers: A) 2 x SSC, 0.1 % SDS, rt 10 min and B) 0.2 x SSC, 1 % SDS, 68 °C 20 min. 
Two washes were done with buffer A and one wash with buffer B, monitoring 32P levels 
with a Geiger counter. The membranes were placed in a sealed box with unexposed film 
overnight at -80 °C. The film was developed the next day.   
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Growth of Streptomyces Cultures. 
 
R2YE+ medium (per L): 103 g sucrose, 2 g tryptone, 4 g peptone, 4 g yeast extract, 10 g 
glucose, 1 g casamino acids, 0.25 g K2SO4, 10.12 g MgCl2·6H2O, 100 mLTris-HCl 
(0.25M, pH 7.2), 80 mL CaCl2·2H2O (3.68%), 5 mL 1N NaOH, 10 mL KH2PO4 (0.5%), 
2 mL trace soln, 2 mL element soln. (pH 6.5) 
   
R5A+ medium (per L): 0.25 g K2SO4, 10.12 g MgCl2·6H2O, 10 g glucose, 0.1 g 
casamino acids, 5 g yeast extract, 21 g MOPS, 0.2 mL trace soln, 2 ml element soln. (pH 
6.8) 
 
Trace soln (per L): 40 mg ZnCl2, 200 mg FeCl3·6H2O, 10 mg CuCl2·2H2O, 10 mg 
MnCl2·4H2O, 10 mg Na2B4O7·10H2O, 10 mg (NH4)6Mo7O24·4H2O 
 
Element soln (1 L, 500x): 3 g CoCl2·6H2O, 1.5 g (NH4)2Fe(SO4)2·6H2O, 1.5 g 
ZnSO4·4H2O, 1.5 g MnSO4·7H2O.       
 
 Seed cultures (50 mL R2YE+ with glass beads) were inoculated from cell stocks 
and allowed to grow for 3-4 days at 28 °C shaking at 250 rpm. These cultures typically 
include 20 µg/mL hygromycin B, 8 µg/mL nalidixic acid, and 20 µg/mL apramycin (if 
the strains include thnL or thnK). These cultures were used to inoculate production 
cultures (1-1.5 ml into 20-30 mL R5A+). Cobalamin (1 µM) is added to the medium 
when desired. (3S,5S)-carbapenam production was monitored by the CarC CFE assay. 
 
CarC Expression and Cell-Free Extract Isolation. 
 
 The carC gene in pET24a (3) was transformed into E. coli Rosetta 2(DE3) for 
expression. The cells were grown at 37 °C in LB medium supplemented with 35 mg/L 
ferrous ammonium sulfate hexahydrate and protein expression was induced with IPTG 
when the optical density reached 0.6. The cultures grew overnight at 19 °C and were then 
pelleted by centrifugation (4,000 × g). The cell paste was frozen for later use. Lysis 
Buffer (10% glycerol, 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) was 
added to cell paste (~ 3 mL buffer for 1 g of cells) along with 1 mg/mL lysozyme and the 
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cells were resuspended. The mixture was sonicated on ice and then centrifuged at 10,000 
× g for 30 min.  The supernantant was used as the cell-free extract and was frozen at -80 
°C for storage. 
 
 
CarC CFE Assay. 
(0.5-1 mL volume) 
8 mM α-ketoglutarate 
80 µM ammonium iron(II) sulfate hexahydrate  
1-2 mM ascorbic acid 
62-63% (by vol) cell-free medium from Streptomyces culture 
25% (by vol) CarC CFE 
 
After mixing, reactions are typically run for 1-1.5 h at 28 °C.  200 µL aliquots are plated 
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Chapter 5 
 
Thienamycin RS Enzymes: Current State and 




 When faced with the challenge of discerning the functions of the thienamycin RS 
enzymes, we initially favored traditional biosynthetic approaches. Gene knockout strains 
were not achievable in S. cattleya, but Dr. Rongfeng Li was able to generate such strains 
in a related carbapenem producer, S. argenteolus (1). Early efforts with the gene 
knockouts in this strain included cross-feeding experiments (K, L, P), chemical 
complementation with potential synthetic intermediates (K, L, P), and attempted isolation 
of pathway intermediates (L). Unfortunately, all of these strategies proved ineffective, 
motivating a move to in vitro experimentation. In addition to the in vitro work already 
discussed (Chapters 3 and 4), further groundwork has been laid in the areas of the ThnK 
mechanism and structure, the activity of ThnK homologs, and the chemistry performed 
by ThnL and ThnP. Now recent progress is discussed in these areas, highlighting 
possibilities for future experimentation, and concludes with a proposal for thienamycin 
biosynthesis. 
 
Results and Discussion: ThnK Mechanism and Structure 
 The enzymatic activity of ThnK as well as an analysis of its variable specificities 
for the C2-thioether were addressed in Chapters 3 and 4, respectively. It was established 
that ThnK requires an Fe-S cluster and is dependent on cobalamin (Cbl). Mechanistically, 
ThnK likely follows the current proposal for Class B methylases (Figure 1.11), whereby a  
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methylcobalamin (Me-Cbl) intermediate is thought to transfer a methyl group to the 
substrate (2). The accumulation of SAH and 5’-dA in a 1:1 ratio (Figure 3.1) and the 
overall retention of absolute configuration of the terminal methyl in the C6-side chain (3) 
support this mechanism. Isolation of a Me-Cbl intermediate from the enzymatic reaction 
would provide additional evidence of the method of methylation. Furthermore, electron 
paramagnetic resonance (EPR) could be used in an attempt to detect a radical 
intermediate, while Mössbauer spectroscopy may confirm the presence of the [4Fe-4S] 
cluster. Kinetic experiments might yield additional mechanistic insight as well. We have 
completed an initial time course for ThnK, measuring 5’dA accumulation when the 
enzyme is incubated with the trans CoA-carbapenam 48 (Figure 5.1). Enzymatic turnover 
is likely complex, involving for a single catalytic cycle the binding of two molecules of 
SAM (one for the 5’dA radical, one as the methyl donor) and the substrate, the formation 
of the 5’-dA radical, hydrogen atom abstraction, and methyl transfer to the Cbl and then 
to the substrate.  
Figure 5.1: 5'-dA accumulation with ThnK. 
 












ThnK, by comparison, is more soluble than some of its Class B family members 
(4, 5), so we have begun a structural collaboration with Dr. Amie Boal at the 
Pennsylvania State University. Currently, no structure is available of any Class B protein, 
and a crystal structure of ThnK would offer valuable information about the coordination 
of binding and chemical events. Hydrogen atom abstraction and methyl donation from 
Cbl may occur from opposite faces of the substrate and define the stereochemistry of the 
methylation.  
Results and Discussion: ThnK Homologs  
While thienamycin contains a C6-hydroxyethyl side chain, not all complex 
carbapenems contain two carbons on their C6-extensions. There are multiple examples 
such as PS-6 from S. cremeus (6) and the asparenomycins from S. tokunonensis (7) where 
the alkyl appendage contains three carbons (Figure 5.2). The double methylation by 
ThnK (8) suggests that a homolog could be responsible for adding all three carbons in 
these related species. An analysis of the ThnK homologs from S. cremeus (CreK) and S. 
tokunonensis (TokK) may yield insight into the control mechanism for the number of 
carbons that are added, which would aid future engineering efforts. Furthermore, CreK 
and TokK, if soluble, provide additional chances for obtaining an x-ray crystal structure 
of a Class B enzyme. 
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 Work was begun on CreK and TokK in collaboration with Erica Sinner (JHU, 
CBI program). Initially, both genes were cloned into pET29b (C-His6 construct) and 
transformed into E. coli Rosetta 2(DE3) also containing the plasmid pDB1282 (9), which 
over-expresses an Fe-S cluster operon. Expression tests in LB medium supplemented 
with Cbl (14 mg/L) showed a moderate level of soluble protein for TokK, but lower 
amounts for CreK. The creK gene was then moved to pET28b to generate His6-tags at 
both ends of the protein. This construct was then placed into Rosetta2 + pDB1282, as 
done previously, and was also put into E. coli BL21 + pDB1282, along with the plasmid 
pG-KJE8 (10) that allows for co-expression of chaperones to assist protein folding. 
Additionally, the original pET29b/creK plasmid was put into BL21 + pDB1282 + pG-
KJE8. CreK solubility was still problematic, but the BL21 pET29b/creK + pDB1282 + 
pG-KJE8 strain appears to give soluble CreK by SDS-PAGE, though not in high purity. 
 Activity assays were started with ThnK to assess whether RS activity could be 
obtained from an aerobic protein purification. The Rosetta 2 pET29b/thnK + pDB1282 
strain was grown in ethanolamine-M9, as previously described (8). The purification was 
performed under an argon atmosphere and with sparged buffers whenever possible to 
reduce exposure to oxygen. Assay reactions included methyl viologen, NADPH, SAM, 
Me-Cbl, and the cis pantetheinyl-carbapenam 11. Anaerobic ThnK reactions do not 
require Me-Cbl, but it was hoped that this addition would improve activity under slightly 
aerobic conditions. When the assay samples were filtered for analysis, it was noted that 
the red color associated with the Me-Cbl was predominately with the protein fraction, 
possibly indicative of cofactor binding with ThnK. By LC-HRMS (negative mode), the 
methylated product of 11 could be observed and was absent from the no-substrate control 
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reaction (Figure 5.3). We noted that the enzyme was more active if the buffer-exchange 
step was omitted after immobilized metal ion affinity chromatography. Using the enzyme 
as soon as possible may prevent additional oxidative damage. The presence of the 
methylated product was encouraging as it was the first demonstration of “aerobic” 
activity from ThnK, opening the door for additional RS activity screening under low 
oxygen tension.  
Having observed methyl transfer activity with ThnK as a positive control, we next 
assayed TokK, which was expressed, purified, and assayed as described above for ThnK. 
Reactions were again conducted with Me-Cbl, which appeared to bind to the protein as 
was seen with ThnK. TokK produced a compound that matched the methylated product 




























Figure 5.3: Extracted-ion chromatograms (EICS) showing “aerobic” methylation by 
ThnK. (Detection in negative mode) 
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of ThnK by mass and retention time (Figure 5.4), suggesting a comparable enzymatic 
activity. With both ThnK and TokK, multiple methylations were not detectable, though 
we attribute this to a decrease in activity due to the presence of oxygen. It is still 
anticipated that TokK is capable of catalyzing three methylations when analyzed in a 
more strictly anaerobic context. Overall, the encouraging activity observed with TokK 
paves the way for future experiments with this and other ThnK orthologs. 
Results and Discussion: ThnL and ThnP 
Demonstrating in vitro activity for ThnL and ThnP continues to be of central 
interest, especially because their catalytic activities are likely unprecedented among Cbl-
dependent RS enzymes. While the wild type thnK gene as a C-terminal-His6 construct in 





























Figure 5.4: Extracted-ion chromatograms (EICS) showing “aerobic” methylation by 
TokK. (Detection in negative mode) 
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E. coli was sufficient to obtain soluble protein, this strategy was not successful for ThnL 
and ThnP. Both the thnL and thnP genes were codon-optimized for expression in E. coli, 
ligated to the pET29b vector, and transformed into the BL21 strain along with plasmids 
providing the Fe-S cluster operon and molecular chaperones (pDB1282 and pG-KJE8, 
respectively). With this new expression strategy, soluble ThnL and ThnP could be 
obtained (Figure 5.5), albeit with some impurities. 
With soluble protein, we expressed, purified, and anaerobically assayed ThnL and 
ThnP as described for ThnK (Chapter 3). The CarC competition assay outlined in Chapter 
4 suggested that ThnL acted directly after ThnE/M and used the (3S,5S)-carbapenam 3 as 
Figure 5.5: SDS-PAGE gel showing soluble ThnK, L, and P. 
ThnK and ThnL were grown in M9 medium + Cbl and were purified anaerobically, 
while ThnP was grown in LB medium + Cbl and was purified aerobically. The red 
arrow indicates the band corresponding to ThnP, which is slightly larger than ThnL. 
K –  78 kDa 
L –   54 kDa 
P –  55 kDa 





its substrate. Thus, the ThnL assay included 3 as well as coenzyme A (CoA). The 
reaction with 3, however, produced comparable levels of SAH and 5’-dA to the no 
substrate control (Figure 5.6); so if we are observing activity, it is very slight. 
Importantly, if ThnL is not a methylase, it may not produce significant amounts of SAH. 
Additional expression and/or assay conditions will need to be undertaken with ThnL, 
including testing other possible thiols, such as phosphopantetheine. 
In parallel with the experiment above, we elected to try refolding insoluble ThnL 
from inclusion bodies, a strategy that worked well for GenK (4). The same thnLopt strain 
described above was grown in LB medium, but without induction of the Fe-S operon or 
chaperones. The inclusion bodies were isolated and solubilized as outlined for GenK (4), 














Figure 5.6: LC-MS/MS detection of enzymatic SAM-derived coproducts 
SAH (385.4 → 136 m/z) and 5′-dA (252.1 →  136 m/z) with ThnL. 
The extracted-ion chromatograms (EICs) for the transitions of 5′-dA and SAH are 
shown for the reaction with compound 3 (blue) and the no substrate control 
(black).  
113	  
but our refolding buffer also contained 50 µM hydroxocobalamin (HO-Cbl). The 
procedure appeared to successfully resolubilize ThnL, and we note the red color from the 
HO-Cbl persisted with the protein fraction after concentration as evidence of proper 
refolding. This resolubilized ThnL was frozen and taken to PSU for anaerobic 
reconstitution of the Fe-S cluster. While performing the reconstitution, however, the 
protein appeared to precipitate out of solution and activity could not be observed. Yet, the 
overall refolding approach still remains a viable option and is worth further optimization. 
ThnP was also assayed with the (3S,5S)-carbapenam 3 and CoA in a similar 
manner to ThnL, although we do not believe 3 to be the substrate for ThnP. This reaction 
produced background levels of SAH and 5’-dA (Figure 5.7), suggesting that either the 
protein is not active or 3 is not the correct substrate. 














Figure 5.7: LC-MS/MS detection of enzymatic SAM-derived coproducts 
SAH (385.4 → 136 m/z) and 5′-dA (252.1 →  136 m/z) with ThnP. 
The extracted-ion chromatograms (EICs) for the transitions of 5′-dA and SAH are 
shown for the reaction with compound 3 (blue) and the no substrate control 
(black).  
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We have tried additional ThnP assays with substrates for ThnK, including 
compounds 11, 47, 48, and 49 (Figure 5.8) as well. These reactions produce low, but 
above background levels of 5’dA, perhaps signifying enzymatic activity. LC-HRMS 
analysis showed evidence of methylase activity, although the turnover was much less 
than that observed for ThnK (Figure 5.9). Perhaps, even if ThnP is not primarily a 
























11 47 48 49
Figure 5.8: ThnK substrates tested with ThnP. 





























Figure 5.9: Extracted-ion chromatograms (EICS) showing low levels of 
methylation by ThnP. 
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More ThnP assays were conducted with compounds 11, 47, 48, and 49 and 
included ThnK in the reaction mixture. The levels of SAH and 5’-dA are not as 
diagnostic for these coupled assays since ThnK activity may obscure any additional effect 
from ThnP. The reactions were analyzed by LC-HRMS for carbapenam(em) products and 
the methylated and ethylated carbapenams were detected, attributable to ThnK activity 
(Figure 5.10). However, compounds corresponding to an additional alkylation or 
desaturation (possible transformations by ThnP) were not observed. Admittedly, if ThnP 























































Figure 5.10: Extracted-ion chromatograms (EICS) to detect 
carbapenam(em) products from ThnK-ThnP coupled assays. 
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was performing the C5-epimeriztion, it would be difficult to discern by retention time and 
there would be no mass difference from the substrate. Additional ThnP assays with a 




Summary and Conclusions 
 
 From the CarC competition assay (Chapter 4), the product of ThnE/ThnM 3 is the 
substrate for ThnL, which we propose to install the C2-thioether (Figure 5.11). Substrate 
screening with ThnK (Chapter 4) revealed that CoA is the preferred C2 side chain for 
sequential ThnK methylations (Chapter 3) and is the likely candidate for the thiol added 
by ThnL. Thus far, thiol attachment by ThnL has not been demonstrated in vitro. The 
activity observed with ThnK also suggested that C5-epimerization occurs after C6-
alkylation (Chapter 3). The C2/3-desaturation is believed to occur after alkylation as well, 
but has yet to be definitively shown. One approach to address the timing of the double-
bond insertion would be to synthesize a C2/3-desaturated analog of 48 and compare the 
activity of ThnK with the analog and 48. While ThnP displays low apparent methylase 
activity, we hypothesize that ThnP performs the epimerization and/or the desaturation. 
Regarding the C2 side chain truncation, ThnR likely acts sometime after C6-alkylation. 
Furthermore, the double-bond is expected to be in place before ThnH removes the 
terminal phosphate from phosphopantetheine (11). ThnQ and ThnT, perhaps in that order, 
are then able to complete the pathway. Additional understanding of the radical SAM 




Materials and Methods 
Substrates Preparation. 
Substrates were synthesized as delineated in Chapter 2. 
Mass Spectroscopy. 
LC-MS/MS analysis for SAH and 5’dA was conducted as previously outlined (8), 
utilizing Method 1. 
UPLC-HRMS analysis for carbapenams(ems) used prior methods (8), but was 
done in negative mode for detection from “aerobic” protein purification assays. Negative 
mode was found to give a superior signal to noise ratio.  
ThnK Time Course. 
ThnK (5.7 µM, FPLC purified, see Chapter 3) was mixed with 100 mM HEPES 
pH 7.5, 200 mM KCl, 0.5 mM SAM, 1 mM methyl viologen, 2 mM NADPH, and 2 mM 
substrate. Assays were conducted anaerobically at room temperature. 
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Cloning of TokK and CreK. 
 
 The gene clusters containing tokK (S. tokunonensis) and creK (S. cremeus) were 
placed into cosmids by Dr. Rongfeng Li. The two thnK homologs were PCR amplified 









 The PCR products were digested with NdeI and XhoI and ligated into pET29b, 
which had been digested with the same restriction enzymes. The two plasmids, 
pET29b/creK and pET29b/tokK, were verified to be correct by DNA sequencing and 
were electroporated into E. coli Rosetta 2(DE3) with the plasmid pDB1282 (9). 
Additionally, creK was ligated into pET28b using the NdeI and XhoI restriction sites and 
the resulting plasmid was transformed into Rosetta 2(DE3) + pDB1282 as well. Both 
pET29b/creK and pET28b/creK were also electroporated in E. coli BL21 + pDB1282 
along with the chaperone plasmid pG-KJE8 (10). 
 
Expression, Purification, and Aerobic Assays of ThnK and TokK. 
 ThnK and TokK were expressed in ethanolamine-M9 medium as has been 
described (8). Frozen cell paste was resuspended in lysis buffer (10% glycerol, 300 mM 
NaCl, 50 mM sodium phosphate pH 8.0, 10 mM BME, 5 mM imidazole) along with 
lysozyme (1 mg/mL final volume). Cells were lysed by sonication and insoluble material 
was removed by centrifugation (25,000 × g for 30 min at 4 °C).  Soluble ThnK/TokK was 
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bound to TALON CoII resin (Clontech) and purified by immobilized metal affinity 
chromatography (IMAC).  The resin was washed with 5 mM and 10 mM imidazole in 
lysis buffer. 250 mM imidazole in the lysis buffer was used to elute the protein. The 
enzyme was concentrated using Amicon centrifugal filter devices (Millipore) with a 10 
kDa molecular weight limit. The additional step of buffer-exchange of the protein was 
found to be detrimental to activity. All buffers were sparged with argon prior to use and 
the purification was done under a head of argon. Assays included: protein (in buffer from 
IMAC), 100 mM potassium phosphate pH 7.5, 200 mM KCl, 1 mM SAM, 1 mM methyl 
viologen, 2 mM NADPH, 1 mM Me-Cbl, and 1 mM substrate. Assays were run for at 
least 1.5 h prior to LC-MS analysis. 
 
Cloning, Expression, Purification, and Assays of ThnL and ThnP. 
 The genes thnL and thnP were codon-optimized and synthesized by the 
commercial vendors DNA2.0 (Menlo Park, CA) and GenScript (Piscataway, NJ), 
respectively. The thnPopt gene was designed with flanking NdeI and XhoI restriction 
sites, which were used to ligate the gene into pET29b, creating pET29b/thnPopt. Dr. 
Andrew Buller used a similar approach to create pET29b/thnLopt. The terminal C-His6 
constructs for the two genes were transformed into E. coli BL21 + pDB1282 + pG-KJE8. 
Expression and purification of ThnL and ThnP were conducted as described for ThnK 
(8); however, the lysis buffer contained 2-2.5 mM imidazole and washes were done with 
this lysis buffer and lysis buffer with 5 mM imidazole. The ThnL assays with the (3S,5S)-
carbapenam 3 (1 mM) included: 50 mM HEPES pH 7.5, 200 mM KCl, 1 mM SAM, 1 
mM methyl viologen, 4 mM NADPH, 0.5 mM Me-Cbl, 0.5 mM HO-Cbl, 1 mM CoA, 
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and 1 mM cysteine and were run for approximately 2 h. The ThnP assays with 3 were 
carried out in a similar manner, but lacked cysteine and contained 2 mM CoA. Reactions 
with ThnP (79 µM) and compounds 11, 47, 48, or 49 (2 mM) contained 100 mM HEPES 
pH 7.5, 200 mM KCl, 1 mM SAM, 1 mM methyl viologen, and 2 mM NADPH and were 
allowed to react for 6 h. The ThnK-ThnP coupled assays had the same components with 
the addition of ThnK (2.9 µM). 
 
Refolding ThnL from Inclusion Bodies. 
 Refolding of ThnL was performed as delineated for GenK (4), but the ThnL 
refolding buffer included 50 µM HO-Cbl. Anaerobic reconstitution of the Fe-S cluster 
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